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Preventive home visits (PHVs) to support functioning and well-being of older people and to reduce 
the rates of institutionalization and hospitalization have been studied for decades. The importance of 
preventive evidence-based effective means increases as the proportion of older people in the 
population continues to grow. Preventive means to support independence are needed, as many older 
people wish to continue living at their homes as long as possible. At the same time there is an 
economic aim: cost-effective means are needed for assessing and managing early the illnesses and 
disabilities of older people to constrain the growing need for costly hospital care and long periods of 
institutionalization. PHVs might offer one such intervention. However, findings in PHV studies 
have been controversial. 
In this study, with four sub-studies, we explored the effects of PHVs targeted to home-dwelling 
older people. In Study I we systematically reviewed the evidence from randomized controlled trials 
(RCTs) on the effectiveness of PHVs targeted to community-dwelling older people on their 
functioning, well-being and health-related quality-of-life (HRQoL), mortality and use and costs of 
healthcare and social services. In Studies II IV an RCT was carried out to investigate the effects of 
multiprofessional PHV intervention implementing comprehensive geriatric assessment (CGA) of 
independent home-dwelling older people in regard to their HRQoL (15-dimensional [15D] 
measure) and use and costs of healthcare and social services. A new intervention trial was 
performed due to the lack of studies on effects of multiprofessional PHVs on patient-preferred 
outcomes (HRQoL), and their cost-effectiveness. 
A systematic search of databases (PubMed, Ovid Medline, Cochrane Database, DARE, and Cinahl) 
supplemented with a manual search of references from earlier reviews was performed in Study I to 
identify RCTs reporting on the effects of PHV interventions targeted to unselected community-
dwelling older populations. Study I review article included PHV trials with focus on use and costs 
of services and the literature review included a broader selection of RCTs on PHV interventions. 
Relevant studies were independently rated by three investigators as regards methodological quality 
and the extracted data was summarized descriptively. Most of the studies were of good or moderate 
methodological quality and 25 out of 33 studies reported some favourable effects of PHVs, mainly 
on functioning. These positive effects were produced cost-neutrally, as no differences in total costs 
between the intervention and control groups were reported. 
The present PHV intervention study is an RCT (n = 422) examining the effects of a three-visit 
multiprofessional PHV programme implementing CGA targeted to home-dwelling older people 
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randomized into intervention (n = 211) and control (n = 211) groups. The participants in the trial 
were older people (75 years old or older) living in their homes with no regular home help or care in 
Hyvinkää municipality, Finland. The intervention group received three home visits delivered by a 
nurse, a physiotherapist and a social worker. 
In Study II we reported the baseline data and feasibility of the intervention. Randomization was 
successful, with the intervention and control groups being balanced at baseline. PHV intervention 
was found to be feasible among the home-dwelling older people. There were no drop-outs during 
the intervention and feedback at the one-year follow-up was mostly favourable. Only 13% of the 
responders found the home visits not to be beneficial. 
Study III concerned the effects of PHV intervention on the primary outcome of the trial. Measured 
using the 15D instrument, HRQoL in the intervention group declined significantly more slowly, the 
difference between groups in changes after one year being -0.015 (95% CI -0.029 to -0.0016; p = 
0.028 adjusted for age, sex, and baseline value). However, the effect was diluted after the home 
visits were discontinued, and there was no significant difference between the groups at the two-year 
follow-up. There were no differences in mortality between the groups. 
Study IV concerned the use and costs of healthcare and social services of the participants and a 
cost-utility analysis. There were no significant differences in the use of healthcare and social 
services of the participants at baseline or during follow-up, or in the total costs of healthcare and 
social services. There were no significant differences in quality-adjusted life-years (QALYs) gained 
between the groups. However, the cost-utility analysis showed 60% of the incremental cost-
effectiveness ratio -effectiveness plane, suggesting 
that the intervention might be both more effective and less costly compared with usual care. There 
were no reported adverse effects of the intervention. 
To conclude, the available literature provides evidence for some positive effects of PHVs on 
functioning, HRQoL and mortality of older people, although these findings remain controversial. 
These favourable effects of PHV intervention were produced cost-neutrally. There is some evidence 
that PHV interventions are cost-effective, but more research is needed. A multiprofessional PHV 
intervention programme implementing CGA supported the HRQoL of older people during one-year 
of follow-up, although the effect became diminished once the visits were discontinued. No 
significant differences between the groups in costs of healthcare and social services were detected. 
Cost-utility analysis suggested that the intervention might be cost-effective without accruing 
increased costs.  
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Ennaltaehkäiseviä kotikäyntejä iäkkäiden toimintakyvyn ja hyvinvoinnin tukemiseksi sekä 
pitkäaikaishoidon tarpeen ja sairaalahoitojen vähentämiseksi on tutkittu jo useamman 
vuosikymmenen ajan. Iäkkäiden osuus koko väestöstä kasvaa kiihtyvää vauhtia, ja useat iäkkäät 
haluavat asua mahdollisimman pitkään omassa kodissaan, joten heidän itsenäisyyttään tukevia 
ennaltaehkäiseviä keinoja kaivataan. Iäkkäiden toimintakyvyn heikkenemisen ja sairauksien 
aikaiseen tunnistamiseen ja hoitamiseen tarvitaan kustannusvaikuttavia keinoja, jotta pystytään 
hallitsemaan kasvavia sairaalahoidon ja pitkäaikaishoidon kustannuksia. Ennaltaehkäisevät 
kotikäynnit saattaisivat olla yksi keino edellämainittujen tavoitteiden saavuttamiseen, mutta 
aiempien tutkimusten tulokset niiden tehosta ovat olleet ristiriitaisia. 
Tutkimus sisältää neljä osatyötä joiden tarkoituksena on tutkia ennaltaehkäisevien kotikäyntien 
vaikuttavuutta iäkkäillä. Ensimmäisen osatyön (I) tavoitteena oli selvittää ennaltaehkäisevien 
kotikäyntien vaikuttavuutta kotonaan asuvien iäkkäiden toimintakykyyn, hyvinvointiin ja 
terveyteen liittyvään elämänlaatuun, kuolleisuuteen sekä terveys- ja sosiaalipalveluiden käyttöön ja 
kustannuksiin aiheesta julkaistujen satunnaistettujen kontrolloitujen tutkimusten perusteella. 
Osatöissä II-IV tarkasteltiin satunnaistetun kontrolloidun tutkimuksen avulla moniammatillisten 
ennaltaehkäisevien kotikäyntien vaikuttavuutta itsenäisesti kotonaan asuvien iäkkäiden terveyteen 
liittyvään elämänlaatuun 15D mittarilla ja heidän terveys- ja sosiaalipalveluiden käyttöönsä sekä 
kustannuksiin hyödyntäen moniammatillista, kokonaisvaltaista geriatrista arviointia. 
Ensimmäinen osatyö on systemaattinen katsaus, jota varten toteutettiin kirjallisuushaku käyttäen 
PubMed, Ovid Medline, Cochrane Database, DARE ja Cinahl tietokantoja ja aiempien katsausten 
kirjallisuusviitteitä. Katsaukseen hyväksyttiin mukaan tutkimukset, jotka olivat satunnaistetulla 
kontrolloidulla asetelmalla tehtyjä ja koskivat kotona asuville iäkkäille ihmisille suunnatujen 
ennaltaehkäisevien kotikäyntien vaikutuksia. Kolme riippumatonta tutkijaa arvioivat tutkimusten 
metodologisen laadun, ja tuloksia tarkasteltiin systemaattisesti kuvaillen. Suurin osa tutkimuksia oli 
metodologiselta laadultaan vähintään kohtalaisia, ja 22 tutkimusta 33:sta raportoi 
ennaltaehkäisevien kotikäyntien tuottaneen positiivisia vaikutuksia, enimmäkseen toimintakykyyn. 
Tutkimukset eivät raportoineet eroja palveluiden kokonaiskustannuksissa interventio- ja 





Aikaisempien tutkimusten perusteella tarvittiin lisätutkimusta moniammatillisten 
ennaltaehkäisevien kotikäytien vaikutuksista terveyteen liittyvään elämänlaatuun, sekä niiden 
kustannusvaikuttavuudesta. Ennaltaehkäisevien kotikäyntien vaikuttavuutta ei aikaisemmin ole 
tutkittu Suomessa. Suomessa toteutettu satunnaistettu, kontrolloitu tutkimus (n = 422) selvitti 
kolmesta moniammatillisesta ennaltaehkäisevästä kotikäynnistä koostuvan intervention 
vaikuttavuutta itsenäisesti kotona asuvilla iäkkäillä ihmisillä. Tutkittavat olivat 75 vuotta täyttäneitä 
hyvinkääläisiä, jotka asuivat kodeissaan ilman säännöllistä kotiapua tai -hoitoa. Heidät 
satunnaistettiin interventio- (n = 211) ja kontrolliryhmiin (n = 211). Interventioryhmälle tehtiin 
kolme kattavaa geriatrista arviointia hyödyntävää ennaltaehkäisevää kotikäyntiä hoitajan, 
fysioterapeutin ja sosiaalityöntekijän toimesta. 
Osatyö II kuvaa tutkittavien lähtötilanteen sekä intervention toteutettavuuden. Interventio- ja 
kontrolliryhmät olivat samankaltaiset lähtötilanteessa. Ennaltaehkäisevistä kotikäynneistä yhtään ei 
jäänyt tekemättä, ja interventio todettiin mahdolliseksi toteuttaa kotona-asuvien ikääntyneiden 
keskuudessa. Palaute tutkittavilta yhden vuoden seurannassa oli pääosin positiivista ja vain 13% 
vastaajista totesi, ettei kotikäynneistä ollut heidän mielestään hyötyä. 
Osatyö III raportoi tutkimuksen päätulokset, eli intervention vaikuttavuutta terveyttä koskevaan 
elämänlaatuun 15D mittarilla. Yhden vuoden seurannassa interventioryhmän elämänlaatu 15D 
mittarilla mitattuna oli laskenut merkitsevästi hitaammin kuin kontrolliryhmässä, ryhmien välisen 
eron ollessa -0.015 (95% CI -0.029 to -0.0016; p = 0.028 vakioituna iän, sukupuolen ja 
lähtötilanteen arvon mukaan). Ero kuitenkin kapeni kotikäyntien loputtua, eikä kahden vuoden 
seurannassa ryhmien välillä ollut enää merkitsevää eroa. Kuolleisuudessa ei ryhmien välillä todettu 
eroa. 
Osatyö IV raportoi tutkittavien terveys- ja sosiaalipalveluiden käytön ja kustannukset sekä 
kustannusvaikuttavuusanalyysin tulokset. Lähtötilanteessa tai seurannan aikana tutkittavien ryhmien 
välillä ei ollut eroja palveluiden käytössä tai kustannuksissa. Ryhmien välillä ei todettu eroa 
laatupainotetuissa elinvuosissa (QALY). Kuitenkin kustannusvaikuttavuusanalyysi osoitti että 60% 
arvioidusta inkrementaalisesta kustannusvaikuttavuussuhteesta (ICER) osui 
tä 
tutkittu interventio saattaa olla sekä tehokkaampi että edullisempi kuin tavanomainen hoito. 
Interventioryhmän tutkittavista kukaan ei jäänyt pois tutkimuksesta intervention aikana. 
Haittavaikutuksia interventiosta ei raportoitu. 
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Tutkimusten mukaan ennaltaehkäisevät kotikäynnit iäkkäille tuottavat positiivisia vaikutuksia 
heidän toimintakykyynsä, elämänlaatuunsa ja kuolleisuuteensa, mutta tulokset ovat yhä ristiriitaisia. 
Nämä positiiviset vaikutukset saavutettiin kustannuksia lisäämättä. Lisää tutkimuksia 
ennaltaehkäisevien kotikäyntien kustannusvaikuttavuudesta tarvitaan. Moniammatilliset, kattavaa 
geriatrista arviointia hyödyntävät ennaltaehkäisevät kotikäynnit tukivat iäkkäiden terveyteen 
liittyvää elämänlaatua yhden vuoden seurannassa, mutta vaikutus väheni kun kotikäynnit lopetettiin. 
Ryhmien välillä ei havaittu eroa terveys- ja sosiaalipalveluiden kustannuksissa. 




An aging population challenges societies as to how best to offer social and healthcare services to 
older adults. The population aged 65 years and older is sharply increasing in developed countries, 
and the fastest growing proportion is that covering the oldest old (80+). This will have major impact 
on healthcare expenditure, which is particularly driven by the amount of older people receiving 
long-term care in institutions or at home (European Commission 2005). The prevalence of disorders 
associated with aging will increase as the population of over 65-year-olds grows in numbers. 
Multimorbidity increases with age, and it is associated with disability, dependence, impaired quality 
of life (QOL) and mortality. Multimorbidity increases hospital admissions; therefore care 
coordination and addressing the problems early are essential (Prince et al. 2015). 
Effective primary, secondary and tertiary prevention targeted at older people is aimed at reducing 
disease burden and disabilities (Prince et al. 2015). Primary prevention is aimed at preventing the 
onset of a disease and maintaining health and functioning by means such as enhancing healthy 
nutrition, physical activity, treatment of hypertension and avoidance of cigarette smoking. When 
primary prevention is successful, it reduces loss of function, suffering and use and costs of 
healthcare and social services. Secondary prevention is aimed at identifying an established disease 
at its presymptomatic or early stage, and treating, for example, cardiovascular risk factors in 
patients with known heart disease or diabetes (Rubenstein et al. 1998). Tertiary prevention is aimed 
at reducing symptoms and preventing complications of an existing disease, maintaining functioning 
and QOL and minimizing suffering of individuals with existing disabilities and syndromes (Pitkala 
et al. 2018b). 
Several well-designed prevention studies have proven the efficacy of many preventive 
interventions, and evidence supports preventive measures targeted to older people in many areas of 
geriatrics (Rubenstein et al. 1998). Prevention of cardiovascular diseases (including anticoagulation 
to prevent strokes, exercising and healthy nutrition) has been shown effective on older people 
(Allen et al. 2017, Estruch et al. 2018, Sandar et al. 2014). In addition, examples of many areas 
where evidence suggests favourable effects of preventive actions on o
functioning and QOL include healthy nutrition with adequate vitamin D and protein intake, 
exercising to prevent mobility disabilities, cognitive training and alleviating loneliness (Bischoff-
Ferrari et al. 2004, Pahor et al. 2014, Suominen et al. 2015). This also supports implementation of 
multifaceted prevention interventions and programmes, applying comprehensive geriatric 
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assessment (CGA) and further measures targeted to individual needs of older adults (Johansson et 
al. 2009, Lundqvist et al. 2018, Stuck et al. 2002). 
Considering geriatric syndromes, an important target group for preventive measures are 
multimorbid older people. Evidence from prevention studies supports implementation of 
interventions with CGA by a multi-professional team (Beswick et al. 2008). CGA has been shown 
to enhance functioning, to postpone institutionalization and to reduce mortality. There is strong 
evidence of its effect in tertiary prevention (Stuck et al. 2002). If functioning and QOL 
can be maintained closer to their end of life, there may be more value to their late-life years even if 
death cannot be postponed. Therefore, the compression of morbidity could be successful, even 
without the gain of a longer life (Allen et al. 2017).  
Preventive means targeted at supporting older adults  functioning and QOL have been hoped to 
postpone institutionalization and to prevent hospitalization (Markle-Reid et al. 2006, Stuck et al. 
2002). Preventive home visits (PHVs) for older people have been studied for decades. Some studies 
of PHVs targeted to older people have shown favourable effects on functioning, well-being, 
mortality (Fagerström et al. 2009, Stuck et al. 2002) and institutionalization (Elkan et al. 2001). 
Furthermore, the results of some studies suggest in particular that PHV intervention involving 
CGA, and with sufficient intensity of visits and follow-up could produce favourable outcomes 
(Stuck et al. 2002). However, the results of studies concerning their effectiveness on clinical 
outcomes and cost-effectiveness remain controversial (Mayo-Wilson et al. 2014, Tappenden et al. 
2012). In particular, research on the cost-effectiveness of PHV interventions has lagged behind 
(Tappenden et al. 2012).  
This study was aimed at systematically evaluating the evidence from randomized controlled trials 
(RCTs) of PHVs on home-dwelling older adults. In the systematic review we explored PHV effects 
on clinical outcomes such as functioning, health-related quality of life (HRQoL) as well as use and 
costs of health- and social services. In addition, an RCT was performed in Hyvinkää municipality to 
explore the effects of a multi-professional PHV intervention programme 
and use and costs of health- and social services. There was a need for a new intervention trial due to 
a lack of multiprofessional home visit studies which included the social approach (van Kempen et 
al. 2012), and only few studies using patient-preferred outcomes (quality-of-life) (Brettschneider et 
al. 2015) and exploring cost-effectiveness of PHV interventions (Corrieri et al. 2011, Metzelthin et 







Preventive home visits are various types of intervention targeted at community-dwelling people. 
They may include interventions targeted on single health problems or diagnoses such as falls or 
stroke (Elley et al. 2008, Green et al. 2002) or they may be used to screen and manage early 
geriatric syndromes of various types (Imhof et al. 2012, Stuck et al. 2000). Therefore, researchers 
have not agreed on any one definition of preventive home visits. Although term PHV is mostly used 
in literature similar interventions have also been called health-promotion (Behm et al. 2016), case 
management (Granbom et al. 2017) and proactive care interventions (Blom et al. 2018). The term 
PHV is used in this dissertation to refer to all interventions fulfilling following definitions. This 
dissertation is focused on multidimensional PHVs targeted to independent home-dwelling older 
adults.  
The aim of PHVs is to increase independence, well-being and QOL using primary, secondary and 
tertiary prevention activities delivered by healthcare professionals. PHV interventions aim to 
prevent negative long-term outcomes such as mortality and institutionalization (Mayo-Wilson et al. 
2014). The target populations and interventions in PHV studies have been varied. Some trials have 
been focused only on one diagnosed illness or a risk factor, such as falls (Corrieri et al. 2011), 
whereas others have been focused on unselected home-dwelling older populations (Bouman et al. 
2008b, Mayo-Wilson et al. 2014, Toljamo et al. 2005). The intervention deliverers have also varied 
from a single nurse to multi-professional teams of experts. In practice the interventions vary greatly. 
In some interventions the interventionist just delivers specific information or health education, 
whereas others implement extensive interventions such as CGA (Mayo-Wilson et al. 2014, Stuck et 
al. 2002; see chapter 2.1.2. p. 22 for definition of CGA). The variety of PHV definitions and 
interventions is also mirrored in the diversity of studies included in the systematic reviews (Beswick 
et al. 2008, Bouman et al. 2008b, Corrieri et al. 2011, Huss et al. 2008, Markle-Reid et al. 2006, 
Mayo-Wilson et al. 2014, Stuck et al. 2002, Toljamo et al. 2005). 
A systematic review defined PHVs as
aimed at multidimensional medical, functional, psychosocial, and environmental evaluation of their 
problems and resources. This evaluation results in specific recommendations aimed at reducing or 
treating the observed problems and preventing new ones. Follow-up visits are included for the 
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impleme . 2008b). Based on earlier literature and this 
definition, the present studies are focused on multidimensional PHV programmes targeted to an 
unselected home-dwelling older population. Therefore, the literature review does not include 
studies on follow-up home visits directly related to recent hospital discharge, or studies on 
condition-specific interventions, for example exclusively targeted to people with one specific 
disease or diagnosis, fall prevention or cognitive function. 
PHVs are part of national healthcare policy as regards preventive and proactive primary care for 
older adults in several countries, e.g. Denmark, the United Kingdom and Australia (Metzelthin et al. 
2015). However, in most countries PHVs are not used nationwide in the healthcare of older people, 
and in some countries only some municipalities offer PHVs as part of primary-care services (Tøien 
et al. 2018). This includes all Nordic countries except Denmark where the PHVs have been 
provided by law since the 1990s (Finlex 2012). Exploring the extent of use of PHVs in primary care 
is challenging due to the varied target groups of older people and varied ways of implementing the 
intervention. 
In Finland municipalities have offered PHVs to varying degrees. Finnish National Institute for 
Health and Welfare reported 64% of municipalities providing PHVs in 2009. However, only half of 
all municipalities in Finland had answered the survey (Seppänen et al. 2009). The PHVs were 
provided regularly in 80% of these municipalities and others provided them as shorter projects 
(Seppänen et al. 2009). Mostly the PHVs have been targeted to older people 75 years or 80 years 
old, and most interventions included a single home visit (Seppänen et al. 2009). Surveys and 
qualitative thesis studies in Finland have indicated that older people and professionals find the 
PHVs useful (Kaijansinkko 2013, Seppänen et al. 2009), which is in line with studies from other 
Nordic countries (Tøien et al. 2018, van Kempen et al. 2012).  
However, there is a lack of effectiveness and cost-effectiveness studies in Finland, and this evidence 
has been based on international studies (Kaijansinkko 2013, Toljamo et al. 2005). In addition, many 
of the PHV interventions offered have lacked in structure of the interventions, education of the 
interventionists, and follow-up, and multiprofessional teams have been poorly utilized 
(Kaijansinkko 2013, Seppänen et al. 2009). The data on complex health care interventions should 
be considered in the context of underlying social and health care system (Craig et al. 2008). Of the 
studies performed in Nordic countries and included in the literature review all four studies 
performed in Sweden produced some favourable effects (Behm et al. 2016, Granbom et al. 2017, 
Gustafsson et al. 2012, Sahlen et al. 2006), whereas three studies performed in Denmark did not 
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show as favourable results (Gunner-Svensson et al. 1984, Hendriksen et al. 1984, Sorensen et al. 
1988; Table 5; chapter 2.3). However, comparison of these studies is problematic due to 
heterogeneity as the Danish studies have been performed notably earlier. 
Older people see PHVs as an important service for them. In a recent study, older people stated that 
PHVs support their ability to have a good life and to live at home (Tøien et al. 2018). However, 
contradictory findings on PHVs in the literature are likely to explain why they are not widely in use 
as a part of primary care services. It is still unclear who would benefit the most from PHVs and 
what are the most important features of the intervention that should be included in PHV 
programmes to be effective (Mayo-Wilson et al. 2014). There is some evidence that PHVs based on 
CGA are more effective than those based on narrower assessment (Stuck et al. 2002, Huss et al. 
2008). Sufficient follow-up with support for participants has also been seen to be important for 
favourable effects and their stability at follow-up (Stuck et al. 2002).  However, no other clear 
factors have been found to be key features in successful interventions (Stuck et al. 2002, Markle-
Reid et al. 2006, Mayo-Wilson et al. 2014). The active contents of PHVs have been questioned in 
some reviews and there has been argumentation that resource-demanding processes should be 
replaced with more efficient services (Markle-Reid et al. 2006, Mayo-Wilson et al. 2014).  
Furthermore, there is still a scarcity of studies on the cost-effectiveness of PHVs (Mayo-Wilson et 
al. 2014, Metzelthin et al. 2015, Tappenden et al. 2012). Thus, PHVs are not commonly 
recommended as a nationwide service for assessing older people (Mayo-Wilson et al. 2014). 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.2 Comprehensive geriatric assessment (CGA) 
CGA is multidimensional, systematic and holistic approach to assessment and care of older people, 
many of whom are multimorbid. CGA was originally developed to ensure that the problems 
experienced by older people requiring hospital-level care are recognized and acted on. Therefore, 
the effectiveness of CGA has been well explored in hospital settings and less among home-dwelling 
older people (Ellis et al. 2017, Lundqvist et al. 2018). 
The definition of CGA differs somewhat across applications. In a recent review it was stated that 
the most commonly used definition for CGA in the literature was
multidisciplinary process which identifies medical, social and functional needs, and the 
development of an integrated / co-
General components used in most CGA programmes include multidisciplinary teams with specialty 
knowledge, use of standardized instruments to assess physical, cognitive, 
mental and social functioning and limitations, nutritional status, tailoring treatment plans according 
to the findings, clinical leadership and multi-disciplinary team meetings (Ellis et al. 2017, Lundqvist 
et al. 2018). CGA is focused Table 2 describes the dimensions included 
in CGA in various studies. 
CGA is commonly used in geriatrics. It is currently seen as the quality standard for identifying 
geriatric syndromes and treating multimorbid older people (Rikkert 2018). CGA is widely used in 
geriatric hospital settings, especially in geriatric wards but increasingly in all geriatric medicine. In 
reviews of the literature, the main target group for CGA has been older hospital patients with acute 
illnesses (Parker et al. 2018). Furthermore, CGA is used in assessment of older people, for example 
in oncology and pre- and perioperative care of older surgical patients, as it can detect risks that are 
not usually identified in routine care (Dhesi et al. 2018, Fülöp et al. 2018). There is less literature 
and experience on CGA in outpatient settings and primary care. CGA has been used, for example, 
in memory clinics, post-hospitalization follow-ups and PHV interventions (Ellis et al. 2017, 
Lundqvist et al. 2018, Parker et al. 2018, Stuck et al. 2002). CGA is useful and widely used in long-
term care of older patients (e.g. nursing homes). Systematic measures for a structured, reproducible 
and objective process, for example the Resident Assessment Instrument (RAI) process, have been 
developed in long-term care (Pitkala et al. 2018a). The literature suggests that CGA should be 
standardized across healthcare settings to promote better health system coordination and integration 




psychosocial and environmental issues has been successful when assessing and treating older 
populations with multiple health problems and challenges in their everyday lives (Liggins et al. 
2010, Lundqvist et al. 2018, Stuck et al. 2002). CGA has a high prognostic value and can be used to 
predict life expectancy, thus making it a useful tool when making treatment decisions (Dhesi et al. 
2018). In earlier research CGA has shown the potential to improve clinical outcomes while 
reducing health- and social-care costs (Rubenstein et al. 1991). A Cochrane review on the 
effectiveness of CGA in a hospital setting showed that older people who received CGA were more 
likely to be living at home and less likely to be institutionalized up to 12 months after hospital 
admission compared with regular hospital care (Ellis et al. 2017). The results of a recent trial 
concerning CGA in an outpatient setting suggested that CGA might reduce mortality and increase 
quality-adjusted life-years (Ekdahl et al. 2016). In the same trial it was suggested that intervention 
was cost-effective (Lundqvist et al. 2018). However, the total health-care costs increased, partly 
because of the intervention costs but also because of increased survival leading to patients 
consuming healthcare resources for a longer time (Lundqvist et al. 2018). Reviews on CGA suggest 
that its implementation does not increase the total costs of care (Wieland 2003, Ellis et al. 2017). 
The shortage of a knowledgeable and skilled work force is a challenge in including CGA in the care 
processes of older people. Geriatrics is still a minor specialty and unpopular among specialising 
physicians in many countries (Pitkala et al. 2018c). Therefore, there is lack of trained geriatricians 
and other trained workforce personnel in geriatrics. Overall, attitudes towards 
and a general lack of geriatric knowledge impede the development of geriatric care and 
implementation of effective geriatric service models (Pitkala et al. 2018a, Pitkala et al. 2018c). 
CGA has been studied little in outpatient settings. There is no clear conclusion concerning the 
effectiveness of CGA in outpatient settings and how it should be implemented (Lundqvist et al. 
2018). The limited number of geriatricians and skilled geriatric workforce personnel limits the use 
of CGA in community care and long-term care facilities (Pitkala et al. 2018a). Also, there is still a 
lack of cost-effectiveness research on CGA. The long-term impact on health outcomes such as 
quality-adjusted life-years (QALYs) and cost-effects of CGA in the total costs of care should be 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.3 Multiprofessional interventions in prevention 
Multiprofessional teams working in health- and social care are multiform and complex. Several 
terms and definitions are used in the literature exploring multiprofessional programmes. The World 
Health Organization (WHO) defined multiprofessional education as 
of students (or workers) from the health-related occupations with different educational backgrounds 
learn together during certain periods of their education, with interaction as an important goal, to 
collaborate in providing promotive, preventive, curative, rehabilitative and other health-related 
 (WHO 1988). The terms and definitions of collaboration of professionals and disciplines 
in healthcare have been refined over time. The WHO defined collaborative practice as a broad term 
covering teamwork of health workers of different professional backgrounds providing 
comprehensive services. Collaborative practice in healthcare means multiple health workers from 
different professions and disciplines co-operating in different areas of health-related work (e.g. 
prevention, diagnosis, treatment, management) with each other and patients, their families, carers 
and communities for the highest quality of care (Gilbert et al. 2010). 
Multidisciplinary, interdisciplinary and interprofessional are commonly used as synonyms for 
multiprofessional, although they have their own definitions. A profession can be defined as a group 
of people sharing a common body of knowledge and training under a specific professional name 
(e.g. Occupational Therapist), whereas discipline means an academic discipline (e.g. sociology) and 
subspecialties within professions (e.g. geriatrics within healthcare sciences). In a multidisciplinary 
team the professionals work side by side, contributing their dis , 
whereas members of an interdisciplinary team work closely together towards a common goal and 
communicate actively with each other to improve the quality of care (Hammick et al. 2009). 
Therefore, interdisciplinary teamwork has been suggested to replace the term multidisciplinary 
teamwork (Hammick et al. 2009). However, those involved in PHVs have mainly used the term 
multiprofessional team, and it is difficult to define which team model the studies are actually using. 
Webster (2002) also clarifies the terms concerning multiprofessional teamwork, considering care of 
older people, and defining multidisciplinary, interdisciplinary and transdisciplinary teamwork in 
multiprofessional teams. He remarks that these are actually more specific models of 
multiprofessional working, whereas multiprofessional is more an umbrella term covering several 
different methods. In a multidisciplinary team each professional works in a team towards their 




goal striving towards overall coordination of goals. Multiprofessional working may be organized in 
various ways, but overall the goal is to share a common focus, and the older person and his or her 
family and surroundings should be at erapeutic activity 
(Webster 2002). A multiprofessional approach is used in many areas of care in 
primary care and geriatrics, with various models and intensities. However, most research reports do 
not describe whether their use of teamwork is in accordance with multidisciplinary or 
 
The WHO has emphasized the importance of interprofessional and interdisciplinary learning and 
collaborative practice to improve health outcomes and strengthen health systems (Gilbert et al. 
2010). Most research on multiprofessional teamwork in geriatric care concerns hospital settings, for 
example acute geriatric wards, geriatric rehabilitation wards, consulting geriatric teams and geriatric 
outpatient clinics (Stuck et al. 1993, Ellis et al. 2017, Pitkala et al. 2018a). In primary healthcare 
multiprofessional interventions have been used, for example in PHVs, falls prevention, 
polypharmacy interventions and service needs assessment (Stuck et al. 2002, Mayo-Wilson et al. 
2014, Mallet et al. 2007, Baxter et al. 2009). Some community-care services provide 
multiprofessional, patient-centred models of care, but in many settings older people are still offered 
traditional, task-based home nursing (Beswick et al. 2008). 
Earlier research shows the importance of multiprofessional processes when assessing older people 
(Liggins et al. 2010). Multiprofessional assessment combined with an individually tailored 
treatment plan has been identified to promote functional activity, well-being and life satisfaction 
(Johansson et al. 2009). Multiprofessional and multifactorial programmes with individualized 
assessment and interventions have been promising features in studies concerning prevention of 
disability in frail community-dwelling older people (Daniels et al. 2008). In community services 
involving older people, patient-centred models of care, including multiprofessional interventions, 
have shown effectiveness (Beswick et al. 2008). Based on earlier systematic reviews, 
recommendations suggest that employment of a multidisciplinary team is beneficial as a means to 
assess and meet the complex care needs of for older people, many of whom are multimorbid and 
have several challenges in their daily lives (Leichsenring 2012, Liggins et al. 2010, Johansson et al. 
2009). 
When assessing older people, it is important to include primary, secondary and tertiary prevention 
in the programme, as any one person may have problems at several levels (Mayo-Wilson et al. 




have been shown to be successful in many areas of prevention concerning older people, for example 
fall prevention and managing drug interactions (Mallet et al. 2007, Baxter et al. 2009). To be 
successful, it has been argued that preventive assessment and recommendations have to be tempered 
by a holistic, multiprofessional team-based approach and include an individualized care plan 
(Mallet et al. 2007, Ellis et al. 2017, Lundqvist et al. 2018). 
Interdisciplinary teamwork has shown effectiveness in assessment and treatment of older people 
(Gilbert et al. 2010, Johansson et al. 2009, Pitkala et al. 2018a, Stuck et al. 1993). However, 
compared with a multidisciplinary approach interdisciplinary teamwork is not yet as widely in use 
owing to a lack of knowledge, skills and education. Varied terms and definitions and their varied 
use in the literature makes evaluation and research of multiprofessional health work challenging 
(Beswick et al. 2008, Hammick et al. 2009). Most health workers currently working in the field 
have not received interprofessional and interdisciplinary education. Furthermore, the structures of 
health and social care in many settings do not yet support interdisciplinary teamwork, and 
management might not have the skills to utilise interprofessional and interdisciplinary teams 
(Gilbert et al. 2010). Thus, a multiprofessional or multidisciplinary approach is more common than 
an interdisciplinary one. Although shown to be effective in PHV studies a multiprofessional 
approach might not prove as effective as interdisciplinary working, as the professionals involved 
work in parallel and not together towards the same goal (Mallet et al. 2007, Ellis et al. 2017). 
2.1.4 Economic analysis of healthcare interventions 
Evaluating the cost-effectiveness of healthcare interventions is important for comparing 
interventions and their effects and costs. It is also crucial for decision making as both the 
effectiveness and the costs of interventions affect decisions on new public health programmes 
(Smith et al. 2015). Several methods of economic analyses are used in studies on healthcare 
interventions. In this chapter the focus is on the terms and methods used in the context of this 
dissertation. 
Cost-effectiveness analysis compares the costs of new intervention with present care concerning the 
effects on some outcome, e.g. death, whereas cost-utility analysis compares the costs of different 
-adjusted life-year (QALY) is a 
commonly used measure for such units. QALY is a composite indicator which allows combining 
quantity and quality of life on a single index (Smith et al. 2015). It is calculated by weighting each 
life year to reflect the QOL in that year, either as an area under the curve calculation or as a square 




calculating QALY is expressed on a numerical scale from 0 to 1, and HRQoL measures which give 
a single index score on this scale (e.g. EQ-5D, 15D) are commonly used for this. One year lived in 
perfect health is one QALY, whereas a year lived in less than perfect health is worth less (Prieto et 
al. 2003). 
Incremental cost-effectiveness ratio (ICER) is a way of summarizing cost-effectiveness results of a 
study. It expresses a ratio of two differences in costs and in effects of the interventions which are 
being compared. The result indicates the cost of the additional effects of the new intervention. If 
difference in effects are large enough and/or the relative costs are low enough, the new intervention 
is considered cost-effective when compared to the current intervention (Smith et al. 2015). The 
ICER comparisons can be presented as a two-dimensional plot, commonly referred to as the cost-
effectiveness plane (Cohen et al. 2008).  
Calculation and interpretation of confidence intervals on cost-effectiveness ratios are complicated, 
thus, one way of managing the uncertainty around point-estimates of ICERs is to use bootstrap 
resampling where several (e.g. 1000) datasets of the same size as the original are created by 
resampling from the original data. When the results of these bootstrap iterations are plotted on the 
cost-effectiveness plane, the results appear as a cloud of possible outcomes. This represents the 
variability in the original study sample. Then the could can be analysed in different ways, including 
calculating proportions of the points of the cloud falling on different quadrants of the plane, which 






2.2.1 Definition of quality of life (QOL) 
Quality of life (QOL) research is vast. There is no single agreed definition or standard of 
measurement for QOL. In 1997 over 100 different instruments for measuring QOL were identified 
(Cummins 1997). The WHO defines the quality of life as: An individual's perception of their 
position in life in the context of the culture and value systems in which they live and in relation to 
their goals, expectations, standards and concerns. It is a broad-ranging concept affected in a 
l health, psychological state, level of independence, social 
(WHOQOL Group 1994). Usually QOL is defined as being multidimensional, with both objective 
and subjective dimensions. It contains several domains such as material well-being, health, 
productivity, intimacy, safety, place in community, and emotional well-being (Cummins 1997). The 
WHO incorporates six domains in their definition: physical health, psychological health, level of 
independence, social relationships, environment, and personal values and beliefs (Rapley 2003, 
WHOQOL Group 1994). Table 3 describes the dimensions of QOL.  
 
  












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.2.2 Definition of health-related quality of life (HRQoL) 
While quality of life is a broad concept covering all aspects of life, HRQoL is focused on the 
consequences of health status on QOL. It concerns the effects of health, functioning, illness and the 
possible impacts of treatments on a sometimes used as substitutable terms 
in the literature, both QOL and HRQoL have their own meanings and nuances (Calman 1984, 
Cummins 1997). Often HRQoL is illness- or disability-centred, and it may be focused more on 
physical functioning than overall QOL (Cummins 1997). Well-being is also a concept related to 
health and QOL. When measuring well- such as life 
satisfaction and positive emotions, are typically assessed (Healthy People 2010, Vaarama 2009). 
Older people have been observed to score better in positive areas of QOL, i.e. well-being, than 
younger people (Frytak 2000, Vaarama 2009). Table 4 describes the dimensions of HRQoL in 
commonly used measures.  
Table 4. The dimensions of HRQoL in three commonly used measures. 
Measure / 
Dimension 
15D (Sintonen 2001) SF-36 (Ware et al. 1992) EQ-5D (EuroQol Group 
1990) 









Discomfort and symptoms 
Vitality 
Physical functioning  
Role limitations because of 






Pain / Discomfort 
Environment and 
material well-being 








Role limitations because of 
personal or emotional 
problems 
Mental-health perceptions 
Anxiety / Depression 




Social functioning   
Productivity and level of 
independence 
Usual activities Physical functioning  
Role limitations because of 
physical health problems 
Usual activities 
 
Being multidimensional, HRQoL has physical, mental, emotional and social domains (Guyatt et al. 
2007, Ferrans 2005). Although biological and physiological variables and their impacts are often 
assessed when measuring HRQoL, the components it measures are not limited to physical aspects 
of health. QOL researchers generally agree that QOL does not depend on physical health alone, but 




Furthermore, many components of HRQoL assessment require a 
cannot be measured without considering a experiences (Guyatt et al. 2007). This 
makes HRQoL an important patient-reported outcome.  
For more than twenty years researchers have recognized the importance of directly measuring how 
people are feeling, how they are able to function in daily activities, and how their illnesses and 
treatments affect these areas (Guyatt et al. 2007). This has led to an increase in research and use of 
different patient-reported outcomes, such as HRQoL. A multitude of various measures and scales 
have been developed to measure HRQoL (Cummins 1997). HRQoL measures used in research or 
for assessing patients should be valid, reliable and responsive. They should measure what they are 
intended to consistently and be able to detect changes in QOL (Guyatt et al. 2007).  
Many QOL instruments have been developed for selected groups in a population, especially for 
assessing QOL in connection with various medical conditions or procedures, for example disease-
specific, function-specific, and problem-specific instruments, and scales focused on detecting 
adverse effects. However, specific scales are not suitable for use in general populations. Therefore, 
generic instruments for assessing QOL and HRQoL have been developed (Guyatt et al. 2007).  
Not even generic instruments can be used without considering the type of population. Scales 
specifically suitable and valid in their target populations are required, for example to assess 
children, older people or people with cognitive impairment. Generic instruments, on average, are 
not as good in detecting treatment effects as specific instruments. However, they are targeted to 
various aspects of HRQoL. Specific instruments are usually more powerful in detecting treatment 
effects, but they are often too narrow to assess generic HRQoL, and they can sometimes be too 
narrow to detect unexpected treatment effects (Guyatt et al. 2007). There are both discriminative 
scales, which are used to distinguish between who has better and who has worse QOL, and 
evaluative scales, which measure whether people feel better or worse over time. Discriminative 
scales should be reliable, whereas evaluative scales should be responsive. Different scales and 
instruments are needed for different situations, and it is important to determine that the instrument is 
valid in connection with a particular item (Cummins 1997, Guyatt et al. 2007). 
2.2.3 Why should HRQoL be measured? 
Use of patient-reported and patient-important outcomes is aimed at ensuring that we measure the 
outcomes and aspects of life that patients value (Guyatt et al. 2007). HRQoL is a multidimensional 
outcome at individual and population health level. It provides broad summary measures of 




2012). Using HRQoL as an outcome measure in research ensures that clinicians and patients can 
assess a treatment or an intervention not only by the effects it has on physiological aspects, but also 
on the effects it is expected to have on QOL. The expected effects can then be compared with the 
. 2007).  
We can use HRQoL to explore new insights into the relationships it has with risk factors, and 
HRQoL measurements help in determining the burden of preventable diseases, injuries, and 
et al. 2012). HRQoL offers important information on 
care providers, clinicians, healthcare organizers and policy makers that can be used to screen and 
monitor patients as regards their well-being, or in auditing healthcare practice. Population surveys 
on perceived health problems, health-services research or evaluation research can utilize HRQoL 
measures. HRQoL can also help regulators in their assessments of new technologies and healthcare 
policies. HRQoL instruments allow comparisons -being, 
which help to appraise the value that, for example, new healthcare technologies or guidelines in 
healthcare might bring, and they are used, among other things, in the realm of economic analysis 
(Feeny et al. 2013, Rapley 2003, WHOQOL Group 1994). 
In previous literature, a significant difference has been noted between self-reported QOL and proxy 
reports on individuals with disabilities, named the disability paradox. Individuals with disabilities 
have reported having better QOL than in proxy assessment. This may be related to their coping with 
disability. The disability paradox might mirror the way a person has adapted to live with a disability 
and their living environment. Thus, well-being is not merely the absence of illness or disability. 
This paradox underlines the importance of self-reporting when measuring HRQoL (Frytak 2000, 
Noll 2000, Thompson 2012). 
The quality-adjusted life-year (QALY) is a measure that is used in an attempt to represent the 
impact of a therapy on both on the length of life and HRQoL, thus expressing the additional number 
of years a person lives as a result of an intervention and the quality of those life years. QALY offers 
a possibility to assess the effects of an intervention and the costs of intervention and treatment, thus 
making it a tool to incorporate HRQoL in assessment of the cost-effectiveness of an intervention 
(Feeny et al. 2013, Whitehead et al. 2010). 
2.2.4 HRQoL in older adults 
Research on the QOL of older people has been a rapidly growing area of interest. This reflects the 
fact that more and more people spend a longer time at this period of life, as demographic changes 




centre of interest because of the increase of life expectancy and the increasing number of people 
living with a chronic disease (Thompson et al. 2012). Several reports and research initiatives have 
been targeted at the living -age also been 
conducted in several countries, such as Sweden and Germany, in recent years (Noll 2004). In 
research targeted to older people the reduction of morbidity, and not only postponed mortality, is a 
centre of interest, and HRQoL provides good measurements for this purpose (Allen et al. 2017, 
Chatterji et al. 2015). 
As more than half of older adults have been estimated to have some sort of disability, it is important 
to look into how disabilities affect their QOL. Therefore, HRQoL is seen as an important tool in 
assessing older people both as individuals and as a group. Research suggests that higher age, higher 
medical-care costs, reduced leisure-time physical activity, and smoking are associated with lower 
QOL among those with functional limitations (Thompson et al. 2012). Although studies suggest 
that subjective QOL tends to be relatively stable over the different age groups, after the age of 80 
years the physical and social dimensions of QOL tend to decline. Thus, the relative importance of 
the psychological dimension is assumed to increase with age along with losses in other dimensions 
(Vaarama 2009).  
When assessing the QOL of older adults, it is important to consider a possible response shift, 
closely resembling the disability paradox. The results of some studies suggest that older people 
perceive their QOL to be better than among younger people with similar disabilities. One reason 
behind this might be that as people age, they start to view their health more in relation to their own 
age, comparing their well-being with that in people of similar age, and can accept that limitations 
connected with their disabilities have less impact on their overall QOL (Frytak 2000, Thompson et 
al. 2012). Thus, disability does not automatically mean a lower QOL, and research on what items 
support the quality of life in this group of the population is important (Frytak 2000, Thompson et al. 
2012). 
Functioning in activities of daily living (ADL) has been found to have a strong association with all 
QOL dimensions in older people (Baernholdt et al. 2012, Thompson et al. 2012). Furthermore, 
cognitive problems, depression and a number of chronic conditions have been found to be 
associated with the QOL of older people. Thus, early diagnosis and treatment of reduced ADL 
function, disabilities, cognitive 
QOL (Baernholdt et al. 2012). Interventions aimed at increasing physical activity among older 




promotion interventions, e.g. PHVs, implementation of CGA and sufficient support and follow-up 
 (Stuck et al. 2002). 
 
2.3.1 Effectiveness of PHVs on functioning 
It has been suggested that preventive interventions targeted to older people, including PHVs, could 
prevent, postpone or slow down functional impairment, leading to a decrease in subsequent 
undesirable outcomes such as institutionalization (Stuck et al. 2002). Thus, PHV interventions that 
target functional abilities have been widely studied for decades. During the last decade, frailty and 
prevention of frailty has become one focus in PHV studies. Frailty is a syndrome associated with 
adverse health outcomes, often leading to an increase in hospitalization and institutionalization 
(Fried et al. 2001, Fairhall et al. 2015). Frailty is characterized by loss of physiological reserve 
capacity and function, increased susceptibility to acute illness, falls, disability, institutionalization, 
and death (Fried et al. 2001, Behm et al. 2016). 
Earlier studies on PHVs were mainly focused on improving or maintaining functioning (Vetter et al. 
1984). Home visits were considered important for older people, as they often reported symptoms 
too late, and disabilities could create difficulties in travelling to a 
1984). It was also hypothesized that relieving unmet health and social needs and supporting 
functional ability of older people would decrease the rates of hospitalization and institutionalization 
(Sorensen et al. 1988). Since the 1980s to the present, PHVs have been widely explored for their 
effects on functioning, including ADL, instrumental activities of daily living (IADL), and deficits of 
functioning and their prevention. Most investigators have reported the outcomes of functioning as 
estimates of the effects on overall functioning, i.e. ADL and IADL (Bleijenberg et al. 2016, 
Bouman et al. 2008a, Brettschneider et al. 2015, Fabacher et al. 1994, Granbom et al. 2017, Imhof 
et al. 2012, Kono et al. 2016, Melis et al. 2008, Metzelthin et al. 2015, Ploeg et al. 2010, Stuck et al. 
1995, Stuck et al. 2000), but some have reported only some aspects of functioning, for example the 
number of people dependent in connection with specific activities (e.g. eating, personal hygiene) 
(Gustafsson et al. 2012, Sorensen et al.1988, Schraeder et al. 2001, Mayo-Wilson et al. 2014). 








Functioning has been defined and measured in a variety of ways in PHV studies. Most commonly 
functioning is defined by independence or dependence in connection with basic activities of daily 
living (ADL) and instrumental activities of daily living (IADL). It is commonly measured on the 
Barthel scale (ADL) (Mahoney et al. 1965, Brettschneider et al. 2015, Kono et al. 2016), Katz-6 
(ADL) and Katz-15 indices (ADL and IADL) (Katz et al. 1963, Laan et al. 2014, Bleijenberg et al. 
2016, Fabacher et al. 1994, Granbom et al. 2017), the Groningen Activity Restriction Scale (GARS) 
(ADL and IADL) (Kempen et al. 1996, Bouman et al. 2008a, Melis et al. 2008, Metzelthin et al. 
2015), the Lawton scale (IADL) (Lawton et al. 1969, Stuck et al. 1995, Brettschneider et al. 2015, 
Fabacher et al. 1994) and the Older Americans Resources and Services scale (OARS) (ADL and 
IADL) (Fillenbaum et al. 1981, Imhof et al. 2012, Ploeg et al. 2010), although other measures have 
also been used. 
In some studies lists of items related to functioning and daily activities have been used to measure 
functional ability. These items include, for example, the number of restricted activity days in bed 
(Schraeder et al. 2001), difficulty in walking (Gustafsson et al. 2012, Schraeder et al. 2001), urinary 
or faecal incontinence (Schraeder et al. 2001, Sorensen et al. 1988), dressing, cooking (Gustafsson 
et al. 2012, Sorensen et al. 1988), vision (Schraeder et al. 2001, Sorensen et al. 1988), hearing 
(Sorensen et al. 1988), cleaning, shopping, transportation, bathing, going to the toilet, and feeding 
(Gustafsson et al. 2012). 
Many of the more recent studies have been focused on the effects of PHVs on prevention of frailty 
or enhancing the functional abilities of frail older people (Behm et al. 2016, Bleijenberg et al. 2016, 
Fairhall et al. 2015, Granbom et al. 2017, Gustafsson et al. 2012, Kono et al. 2012, Kono et al. 
2016, Melis et al. 2008, Metzelthin et al. 2015). Some PHV studies have concerned the effects of 
preventive and health-promoting interventions in postponing deterioration in frailty (Behm et al. 
2016) and reducing the degree of frailty (Bleijenberg et al. 2016, Granbom et al. 2017, Fairhall et al. 
2015). The definition of frailty has varied in these studies. Most studies focusing on frail 
participants or on prevention of frailty have involved the use of Fried criteria (Fried et al. 2001), or 
a modified version of them (Behm et al. 2016, Gustafsson et al. 2012, Fairhall et al. 2015), or the 



































































































































































































































































































































































































































































































































































Characteristics of target groups and interventions 
Altogether, 24 studies have been carried out to explore the effects of PHVs on functioning, 
functional limitations, or frailty (Behm et al. 2016, Bleijenberg et al. 2016, Bouman et al. 2008a, 
Brettschneider et al. 2015, McEvan et al. 1990, Fabacher et al. 1994, Fairhall et al. 2015, Granbom 
et al. 2017, Gustafsson et al. 2012, Hebert et al. 2001, Imhof et al. 2012,  Kono et al. 2012, Kono et 
al. 2016, Melis et al. 2008, Metzelthin et al. 2015, Pathy et al. 1992, Ploeg et al. 2010, Schraeder et 
al. 2001, Sorensen et al.1988, Stuck et al.1995, Stuck et al. 2000, Van Hout et al. 2010, Van 
Rossum et al. 1993, Vetter et al. 1984). These studies were performed between 1984 (Vetter et al. 
1984) and 2017 (Granbom et al. 2017). 
The participants and interventions in PHV studies targeting functioning, deficits of functioning, and 
frailty have varied in different studies. The mean age of participants in high- and moderate-quality 
studies has ranged from 72 years to 86 years. This variation can be explained by the range of 
minimum age in inclusion criteria of the studies, which varies from 60 years and over (Bleijenberg 
et al. 2016) to 80 years and over (Behm et al. 2016, Brettschneider et al. 2015, Gustafsson et al. 
2012, Imhof et al. 2012).  
The participants of all studies included were independent community-dwelling older people. Six 
studies had no other inclusion or exclusion criteria (McEvan et al. 1990, Metzelthin et al. 2015, 
Pathy et al. 1992, Sorensen et al. 1988, Van Rossum et al. 1993, Vetter et al. 1984). A decline in 
functioning was included as an inclusion criterion in 11 studies (Bleijenberg et al. 2016, Fairhall et 
al. 2015, Granbom et al. 2017, Kono et al. 2012, Kono et al. 2016, Melis et al. 2008, Metzelthin et 
al. 2015, Ploeg et al. 2010, Van Hout et al. 2010, Hebert et al. 2001, Schraeder et al. 2001). 
Common exclusion criteria were a severe decline in cognition, included in nine studies (Behm et al. 
2016, Brettschneider et al. 2015, Fabacher et al. 1994, Fairhall et al. 2015, Granbom et al. 2017, 
Gustafsson et al. 2012, Imhof et al. 2012, Stuck et al.1995, Van Hout et al. 2010), and terminal 
disease, included in eight studies (Bleijenberg et al. 2016, Fabacher et al. 1994, Fairhall et al. 2015, 
Imhof et al. 2012, Ploeg et al. 2010, Stuck et al.1995, Stuck et al. 2000, Van Hout et al. 2010). 
A nurse performed the home visit intervention in most studies (Bleijenberg et al. 2016, Bouman et 
al. 2008a, McEvan et al. 1990, Fabacher et al. 1994, Granbom et al. 2017, Hebert et al. 2001, Imhof 
et al. 2012, Kono et al. 2012, Kono et al. 2016, Melis et al. 2008, Pathy et al. 1992, Ploeg et al. 
2010, Schraeder et al. 2001, Sorensen et al.1988, Stuck et al.1995, Stuck et al. 2000, Van Hout et al. 
2010, Van Rossum et al. 1993, Vetter et al. 1984). However, in five studies multiprofessional home 




Gustafsson et al. 2012, Metzelthin et al. 2015). The number of home visits and duration of the 
intervention varied across the PHV studies targeting functioning. The number of visits ranged from 
one home visit (Behm et al. 2016, Gustafsson et al. 2012, Vetter et al. 1984) to 12 visits during one 
year (Granbom et al. 2017). The duration of intervention ranged from three months (Brettschneider 
et al. 2015, Melis et al. 2008) to 36 months (Stuck et al. 1995, Stuck et al. 2000). When comparing 
the studies, none of these characteristics appeared to have an apparent relationship to favourable 
effects of the intervention. 
Studies involving comparison of PHVs with other active interventions have not shown superiority 
in effectiveness (Bleijenberg et al. 2016, Behm et al. 2016). In one study there was a screening 
intervention (ambulatory care consultation) as a third study arm. Based on this, some of the 
screened participants also received home visits (Bleijenberg et al. 2016). In this RCT both screening 
intervention and a preplanned PHV programme showed effectiveness, with participants in both of 
the intervention groups showing less decline in daily functioning than those in the control group at 
one-year follow-up (Bleijenberg et al. 2016). A three-arm trial carried out to compare the 
effectiveness of a single PHV on functioning with group-session intervention and a control group 
receiving typical care offered by the municipality revealed favourable effects on functioning in both 
intervention groups. In these two groups, at the one-year follow-up tiredness in carrying out daily 
activities was significantly diminished in comparison with that in the control group, but after the 
intervention ended the effect was diluted in the two-year follow-up and there was no significant 
difference between the groups (Behm et al. 2016). This result is consistent with that in other studies, 
indicating that long-lasting effects of interventions aimed at older people are only achieved through 
long-term support after the initial intervention (Stuck et al. 2002). 
Effects on functioning 
Of the 13 studies reporting favourable effects of PHVs on functioning (Table 5), seven reported 
positive effects on ADL (Behm et al. 2016, Bleijenberg et al. 2016, Gustafsson et al. 2012, Kono et 
al. 2012, 2016, Stuck et al. 1995, Stuck et al. 2000) and two on IADL (Fabacher et al. 1994, Stuck 
et al. 2000). Furthermore, one suggested effects on the prevalence of frailty (Fairhall et al. 2015), 
one on the number of falls and prevalence of falls with consequences (Imhof et al. 2012), and one 
on the prevalence of fatigue in performing daily tasks (Schraeder et al. 2001). One study showed 
effects on performing physical and social leisure activities (Granbom et al. 2017).  In many studies 
reporting some favourable results on functioning, not all measured dimensions of functioning were 




Imhof et al. 2012, Stuck et al. 2000) or only a subgroup of participants benefitted from the 
intervention (Kono et al. 2012). Usually there were no differences between groups in IADL 
(Bleijenberg et al. 2016, Bleijenberg et al. 2017, Kono et al. 2012, Kono et al. 2016, Stuck et al. 
1995), although a few studies suggest that the intervention group retained functioning in IADL 
significantly better than the control group (Fabacher et al. 1994, Stuck et al. 2000). Of the 24 
studies exploring the effectiveness of PHVs on functioning, eleven did not show  favourable effects 
(Bouman et al. 2008a, Brettschneider et al. 2015, McEvan et al. 1990, Hebert et al. 2001, 
Metzelthin et al. 2015, Pathy et al. 1992, Ploeg et al. 2010, Van Hout et al. 2010, Van Rossum et al. 
1993, Vetter et al. 1984), and one study revealed favourable results on well-being without a decline 
in functioning (Melis et al. 2008). 
Thus, the studies indicated some favourable findings on functioning, although the effects did not 
usually cover all measured dimensions of functioning and sometimes were relatively small. 
Comparison of studies and their results is challenging as a result of heterogeneity in interventions, 
in outcome measures used and in methods of reporting the outcomes. The effectiveness of PHVs on 
functioning, the target group that would benefit the most, and the characteristics of intervention 
most essential to enhance or maintain functioning remain unclear. These findings are similar to 
those in earlier reviews, where PHVs have been found to have a small effect on functioning, 
although specific aspects of target groups and interventions related to favourable effects have not 
been recognized (Beswick et al. 2008, Markle-Reid et al. 2006, Huss et al. 2008, Mayo-Wilson et 
al. 2014). However, it seems that extended follow-up and support to maintain the functioning of 
older participants is needed after intervention, since the effects of PHVs on functioning may quickly 
become diluted (Stuck et al. 2002, Schraeder et al. 2001, Behm et al. 2016).  
Another challenge in supporting the functioning of older people by means of PHVs is finding the 
right target group for intervention. Well-functioning older people have benefitted more in some 
earlier studies than older people with limitations in functioning (Markle-Reid et al. 2006, Stuck et 
al. 1995, 2000, 2002). However, in this literature review there was no clear difference in 
functioning outcomes between studies that included older people with better functional status 
compared with those that included only those with functional limitations. 
2.3.2 Effectiveness of PHVs on older adult  and well-being 
Self-rated health (SRH), well-being and HRQoL have been used in PHV studies to measure the 
effects that health-promotion interventions have on QOL. In these studies, typically, 




Van Rossum et al. 1993), whereas HRQoL has been focused on the effects on current health and 
functional status of an older person (Cummins 1997, McEvan et al. 1990). The effects of PHVs on 
well-being and HRQoL of older people have been studied less than their effects on functioning. 
However, this area of research has grown in more recent PHV studies. In this review the first 
health-promotion interventions aimed to maintain or improve well-being or HRQoL were 
performed in the 1990s (McEvan et al. 1990, Van Rossum et al. 1993).  
Measures 
Well-being and HRQoL have been assessed by means of a variety of measures in the PHV studies 
under review. The most commonly used measures in HRQoL have been EuroQol-5D (EQ-5D) 
(EuroQol Group 1990, Bleijenberg et al. 2016, Brettschneider et al. 2015, Fairhall et al. 2015, 
Metzelthin et al. 2015, Yamada et al. 2003), Short Form 36 (SF-36) and RAND-36 (Ware et al. 
1992, Bleijenberg et al. 2016, Bouman et al. 2008a, Byles et al. 2004, van Hout et al. 2010). The 
Nottingham health profile (Hunt et al. 1986, McEvan et al. 1990), the McMaster Health Index 
(Chambers et al. 1982, McEvan et al. 1990), The Health Utilities Index Mark 3 (Furlong et al. 2001, 
Ploeg et al. 2010), and WHOQOL-Bref (Skevington et al. 2004, Imhof et al. 2012) were also used 
to measure HRQoL. The Philadelphia morale scale was used in one study to measure overall QOL 
(Lawton et al. 1975, McEvan et al. 1990). In some studies a separate numeric scale (e.g. rate your 
health between 0 [poor health] and 10 [excellent health]) (Van Rossum et al. 1993) or a visual 
analogue scale (VAS) (Sahlen et al. 2006) were used for measuring SRH. Well-being was measured 
in five studies, with different scales and measures (Bleijenberg et al. 2016, Crawford Shearer et al. 
2010, Hebert et al. 2001, Sahlen et al. 2006, Van Rossum et al. 1993). Other items related to QOL 
measured in the PHV studies were depression or mental well-being (Bouman et al. 2008a, 
Brettschneider et al. 2015, Melis et al. 2008, Shapiro et al. 2002, Van Rossum et al. 1993), 
loneliness (Bouman et al. 2008a, Van Rossum et al. 1993), social relationships or social support 
(Bouman et al. 2008a, Hebert et al. 2001, Sahlen et al. 2006, Shapiro et al. 2002) and environmental 
mastery (Bouman et al. 2008a, Shapiro et al. 2002).  
Characteristics of target groups and interventions 
The mean age of the participants varied between 74 years and 85 years in the different studies. The 
participants were community-dwelling older people. In nine studies a decline in functioning was 
used as an inclusion criterion (Bleijenberg et al. 2016, Fairhall et al. 2015, Hebert et al. 2001, Melis 
et al. 2008, Metzelthin et al. 2015, Ploeg et al. 2010, Shapiro et al. 2002, van Hout et al. 2010, 




did not have a large number of exclusion criteria. However, relatively commonly used exclusion 
criteria were terminal illness (Bleijenberg et al. 2016, Fairhall et al. 2015, Imhof et al. 2012, van 
Hout et al. 2010) and cognitive impairment (Brettschneider et al. 2015, Crawford Shearer et al. 
2010, Fairhall et al. 2015, Imhof et al. 2012, van Hout et al. 2010).  
Multiprofessional intervention was used in four studies (Byles et al. 2004, Brettschneider et al. 
2015, Fairhall et al. 2015, Metzelthin et al. 2015) and a single professional (usually a nurse) 
delivered the intervention in thirteen of the studies (Bleijenberg et al. 2016, Bouman et al. 2008a, 
Brettschneider et al. 2015, Crawford Shearer et al. 2010, McEvan et al. 1990, Hebert et al. 2001, 
Imhof et al. 2012, Melis et al. 2008, Metzelthin et al. 2015, Ploeg et al. 2010, Sahlen et al. 2006, 
Shapiro et al. 2002, van Hout et al. 2010, Van Rossum et al. 1993, Yamada et al. 2003) exploring 
effects of PHVs on well-being and HRQoL. The intensities of the interventions varied, from one to 
two visits (Bleijenberg et al. 2016, Byles et al. 2004, McEvan et al. 1990) to at least ten visits 
(Fairhall et al. 2015). The duration of the intervention varied between three months (Crawford 
Shearer et al. 2010, Melis et al. 2008) and 36 months (Byles et al. 2004, Van Rossum et al. 1993).  
Effects on well-being and HRQoL 
Of the studies on the effects of PHVs, seven suggested favourable results on well-being or HRQoL 
(Byles et al. 2004, Crawford Shearer et al. 2010, McEvan et al. 1990, Melis et al. 2008, Pathy et al. 
1992, Shapiro et al. 2002, Yamada et al. 2003), whereas twelve did not show positive effects on 
well-being or HRQoL (Bleijenberg et al. 2016, Bouman et al. 2008a, Brettschneider et al. 2015, 
Fairhall et al. 2015, Hebert et al. 2001, Imhof et al. 2012, Metzelthin et al. 2015, Ploeg et al. 2010, 
Sahlen et al. 2006, Sorensen et al.1988, van Hout et al. 2010, Van Rossum et al. 1993). Favourable 
effects were found on general health (Byles et al. 2004, Pathy et al. 1992, Yamada et al. 2003), 
well-being, morale, life satisfaction and emotional reactions (McEvan et al. 1990, Melis et al. 2008, 
Shapiro et al. 2002), social relationships and loneliness (Byles et al. 2004, McEvan et al. 1990), and 
mastery and purposeful participation in reaching personal goals (Crawford Shearer et al. 2010, 
Shapiro et al. 2002). One study revealed a favourable effect in a subgroup of participants who rated 
their own health as poor at baseline (Yamada et al. 2003). 
2.3.3 Effectiveness of PHVs on use and costs of healthcare services and their cost-effectiveness  
One of the main aims of PHV interventions has been economic: to reduce the use of demanding 
healthcare and social services, such as hospitalization and institutionalization (Elkan et al. 2001, 
Markle-Reid et al. 2006, Stuck et al. 2002, Tappenden et al. 2012). The hypothesis is that by 




stage, PHV interventions may reduce costly specialist care and institutionalization (Elkan et al. 
2001, Markle-Reid et al. 2006, Stuck et al. 2002). Earlier PHV studies were focused more on 
exploring the effects of PHV intervention on institutionalization (e.g. nursing home admissions) and 
primary-care use (Gunner-Svensson et al. 1984, Fabacher et al. 1994, Stuck et al. 1995, van Rossum 
et al. 1993, Vetter et al. 1984). Although most of these studies concerned some dimensions of 
services use or costs, only a few explored the cost-effectiveness of PHV intervention 
(Brettschneider et al. 2015, Fairhall et al. 2015, Melis et al. 2008, Metzelthin et al. 2015, Stuck et al. 
1995, Tappenden et al. 2012). 
Measures 
Altogether, 27 studies reported outcomes concerning some variables related to healthcare and social 
services use or costs (Bleijenberg et al. 2016, Brettschneider et al. 2015, Byles et al. 2004, Dalby et 
al. 2000, McEvan et al. 1990, Fabacher et al. 1994, Fairhall et al. 2015, Frese et al. 2012, Gunner-
Svensson et al. 1984, Hebert et al. 2001, Hendriksen et al. 1984, Imhof et al. 2012, Kono et al. 
2013, Kono et al. 2016, Melis et al. 2008, Metzelthin et al. 2015, Pathy et al. 1992, Ploeg et al. 
2010, Sahlen et al. 2006, 2008, Schraeder et al. 2001, Shapiro et al. 2002, Sorensen et al.1988, 
Stuck et al. 1995, Stuck et al. 2000, van Hout et al. 2010, van Rossum et al. 1993, Vetter et al. 
1984). Institutionalization and hospitalization were the most reported outcomes, with 
institutionalization rates reported in 15 studies (Bleijenberg et al. 2016, Brettschneider et al. 2015, 
Byles et al. 2004, Dalby et al. 2000, Fabacher et al. 1994, Fairhall et al. 2015, Gunner-Svensson et 
al. 1984, Hebert et al. 2001,  Melis et al. 2008, Metzelthin et al. 2015, Shapiro et al. 2002, Stuck et 
al. 1995, Stuck et al. 2000, van Hout et al. 2010, van Rossum et al. 1993) and rates of 
hospitalization reported in 14 (Bleijenberg et al. 2016, Byles et al. 2004, Fabacher et al. 1994, 
Fairhall et al. 2015, Imhof et al. 2012, Kono et al. 2013, Kono et al. 2016, Melis et al. 2008, 
Metzelthin et al. 2015, Schraeder et al. 2001, Stuck et al. 1995, Stuck et al. 2000, van Hout et al. 
2010, van Rossum et al. 1993). Other reported variables related to health- and social-care use were 
primary-care use, general practitioner (GP) visits and/or consultations, emergency department 
visits, outpatient-clinic visits and community services use including, for example, meals-on-wheels, 
home nursing care and home help. 
Total costs of healthcare and social services were reported in eleven studies (Brettschneider et al. 
2015, Fairhall et al. 2015, Kono et al. 2016, Melis et al. 2008, Metzelthin et al. 2015, Ploeg et al. 
2010, Sahlen et al. 2008, Schraeder et al. 2001, Stuck et al. 1995, Stuck et al. 2000, van Rossum et 




2008, Metzelthin et al. 2015, Ploeg et al. 2010, van Rossum et al. 1993). A cost-effectiveness 
analysis was performed in five studies (Brettschneider et al. 2015, Fairhall et al. 2015, Melis et al. 
2008, Metzelthin et al. 2015, Stuck et al. 1995).    
Characteristics of target groups and interventions 
The mean age of participants in the studies exploring services use and costs and cost-effectiveness 
varied from 72 years (Fabacher et al. 1994) to 85 years (Brettschneider et al. 2015, Imhof et al. 
2012). In these trials the intensity of interventions varied from one visit (Bleijenberg et al. 2016, 
Byles et al. 2004, Dalby et al. 2000, Gunner-Svensson et al. 1984, Vetter et al. 1984) to over ten 
visits (Fairhall et al. 2015). The intervention was multiprofessional in four of the PHV studies 
exploring services use and costs (Brettschneider et al. 2015, Byles et al. 2004, Fairhall et al. 2015, 
Metzelthin et al. 2015). In the other studies, the intervention was delivered by a single professional, 
most often a nurse (Table 5). 
The duration of intervention varied from three months (Brettschneider et al. 2015, Melis et al. 2008) 
to 36 months (Byles et al. 2004, Stuck et al. 1995, Stuck et al. 2000, van Rossum et al. 1993) in 
both the studies with favourable findings and those that did not detect favourable differences. 
However, in the studies with short intervention the follow-up period tended to be short. Thus, the 
stability of outcomes over time cannot be assessed in the studies with short interventions. 
Effects on use and costs of services 
In studies exploring the effects of PHVs on healthcare and social services use and costs, ten 
reported some favourable outcomes (Fairhall et al. 2015, Hendriksen et al. 1984, Imhof et al. 2012, 
Kono et al. 2013, Melis et al. 2008, Sahlen et al. 2008, Shapiro et al. 2002, Stuck et al. 1995, 2000, 
van Rossum et al. 1993). Only three studies showed the intervention group to be less likely to be 
institutionalized (Melis et al. 2008, Shapiro et al. 2002, Stuck et al. 1995), and one study suggested 
a higher risk of institutionalization in the intervention group (Byles et al. 2004). Four studies 
showed less hospitalization in the intervention group (Imhof et al. 2012, Melis et al. 2008, Kono et 
al. 2013, van Rossum et al. 1993), although one of these showed this favourable effect only in 
connection with costly hospitalizations (Kono et al. 2013).  
The intervention group used more primary care or GP services in four studies (Bleijenberg et al. 
2016, Metzelthin et al. 2015, Stuck et al. 1995, Stuck et al. 2000) and more community services in 
two studies (van Rossum et al. 1993, Vetter et al. 1984). These results were to be expected, as the 




primary-care professional or community services if any risks were detected. In one study, increased 
use of GP services occurred in connection with a lower risk of institutionalization (Stuck et al. 
1995). In another study, greater use of community services occurred in connection with lower use 
of specialist outpatient clinic services and less hospitalization in the intervention group (van 
Rossum et al. 1993).  
None of the studies (n = 11) showed any statistically significant differences in total costs between 
intervention and control groups. Some variation in total costs between the groups was found, with 
three studies suggesting slightly lower total costs (Kono et al. 2016, Ploeg et al. 2012, Sahlen et al. 
2008) and five studies suggesting slightly higher total costs (Brettschneider et al. 2015, Fairhall et 
al. 2015, Metzelthin et al. 2015, Schraeder et al. 2001, van Rossum et al. 1993) in the intervention 
group. However, these differences were not reported to be statistically significant. One study 
showed healthcare costs to be significantly higher in the intervention group, although there was no 
significant difference in total costs (Metzelthin et al. 2015). The participants in the intervention 
group in this study were more disabled and more frail at baseline, which might explain the 
difference detected in healthcare costs (Metzelthin et al. 2015). 
Of the five studies exploring cost-effectiveness, three showed the intervention to be cost-effective 
(Fairhall et al. 2015, Melis et al. 2008, Stuck et al. 1995). The level of costs at which the 
intervention was evaluated to be cost-effective varied from $6,000 per gained disability-free year 
(Stuck et al. 1995) to willingness to pay  to $50,000 per successfully treated participant 
(Fairhall et al. 2015, Melis et al. 2008). Two studies exploring cost-effectiveness showed the 
intervention not to be cost-effective (Brettschneider et al. 2015, Metzelthin et al. 2015).  
The participants tended to be older in the studies which suggested favourable effects in services use 
and/or costs, with five studies having participants over 80 years old on average (Fairhall et al. 2015, 
Imhof et al. 2012, Melis et al. 2008, Stuck et al. 1995, Stuck et al. 2000) and only three studies with 
participants with a mean age of 80 years or younger (van Rossum et al. 1993, Sahlen et al. 2008, 
Shapiro et al. 2002). In the studies which did not show favourable effects in services use and/or 
costs, the mean age of the participants was over 80 years in only three studies (Brettschneider et al. 
2015, Ploeg et al. 2010, van Hout et al. 2010), and 80 years or younger in nine studies (Bleijenberg 
et al. 2016, Dalby et al. 2000, Fabacher et al. 1994, Gunner-Svensson et al. 1984, Hebert et al. 2001, 
Kono et al. 2013, Kono et al. 2016, Metzelthin et al. 2015, Schraeder et al. 2001). 
In the studies exploring the effects of PHVs on healthcare and social services use and costs, 




2000, Fairhall et al. 2015, Hebert et al. 2001, Kono et al. 2013, Kono et al. 2016, Melis et al. 2008, 
Metzelthin et al. 2015, Ploeg et al. 2010, Schraeder et al. 2001, Shapiro et al. 2002, van Hout et al. 
2010). In those that suggested favourable effects on services use and costs only three of eight 
studies included functional decline as an inclusion criterion (Fairhall et al. 2015, Melis et al. 2008, 
Shapiro et al. 2002), whereas of the studies that did not detect differences in services use and costs 
in favour of the intervention nine of sixteen used functional decline as an inclusion criterion 
(Bleijenberg et al. 2016, Dalby et al. 2000, Hebert et al. 2001, Kono et al. 2013, Kono et al. 2016, 
Metzelthin et al. 2015, Ploeg et al. 2010, Schraeder et al. 2001, van Hout et al. 2010).  However, in 
one study it was noted that the intervention was more likely to be cost-effective in the 
subgroup than among those with better functional ability (Fairhall et al. 2015). 
The interventions which produced some favourable results on use and costs of healthcare and social 
services tended to be more intensive. Most of the interventions producing some favourable results 
included four (Imhof et al. 2012, Shapiro et al. 2002, Stuck et al. 2000, Stuck et al. 1995, van 
Rossum et al. 1993) to at least ten (Fairhall et al. 2015) visits, with only one intervention with two 
home visits producing favourable results (Sahlen et al. 2008). In studies which did not reveal 
favourable effects on services use and costs, most interventions included only one (Bleijenberg et 
al. 2016, Byles et al. 2004, Dalby et al. 2000, Gunner-Svensson et al. 1984, Vetter et al. 1984) to 
four (Fabacher et al. 1994, Kono et al. 2016, Schraeder et al. 2001, van Hout et al. 2010) visits, with 
only one study with a maximum of 12 contacts (Hebert et al. 2001). 
2.3.4 Effectiveness of PHVs on mortality 
Of the RCTs, 21 explored the effects of intervention on mortality (Table 5). Most studies did not 
reveal significant differences in mortality between the intervention and control groups. However, in 
seven studies the risk of dying was significantly lower in the intervention group (Brettschneider et 
al. 2015, Hendriksen et al. 1984, Pathy et al. 1992, Sahlen et al. 2006, Schraeder et al. 2001, 
Shapiro et al. 2002, Vetter et al. 1984). One study showed a lower risk of dying or becoming 
institutionalized in the intervention group vs. the control group (Frese et al. 2012).  
There were no clear common characteristics in these seven studies. The mean age of participants 
varied from 69 years (Pathy et al. 1992) to 85 years old (Brettschneider et al. 2015) and decline in 
functioning was used as an inclusion criteria in two of these studies (Schraeder et al. 2001, Shapiro 
et al. 2002). In one study with favourable findings in mortality the intervention was 





Preventive home visits have been used for decades to support home-
functioning and to prevent admission to institutional care. Nurses have most commonly been the 
professionals implementing the intervention. However, multi- or interprofessional teams have been 
increasingly used in these interventions. 
Comprehensive geriatric assessment has shown effectiveness as regards 
in a high number of trials. It has also been implemented as part of a multidimensional approach in 
PHVs. Since the 1990s HRQoL and well-being have been used as outcome measures in some PHV 
trials, most of these studies having been performed during the past 15 years. HRQoL is considered 
to be a patient-centred outcome. However, only five studies have explored the effects of PHVs on 
QALYs. 
Of the 33 studies, 25 showed favourable effects of PHVs on some of the outcomes explored. Most 
of these studies did not show favourable effects in all the dimensions explored. Of the studies, eight 
did not show any favourable effects of PHV interventions on older people (Bouman et al. 2008a, 
Dalby et al. 2000, Gunner-Svensson et al. 1984, Hebert et al. 2001, Metzelthin et al. 2015, Ploeg et 
al. 2010, Sorensen et al.1988, van Hout et al. 2010). Although in many studies the findings were 
modest, this would suggest that PHVs have the potential to produce some favourable effects on 
functioning, well-being and HRQoL, mortality, and healthcare and social services use and costs. 
The participants, interventions, durations of interventions and follow-ups, and outcomes used in the 
PHV studies were varied. Furthermore, these PHV studies were performed over a long time period, 
some even decades apart from each other. During time periods of this length, healthcare systems 
have changed considerably, which in turn changes the settings in which these studies were 
performed. These features create a challenge in comparing the studies, their results and what items 
might have been important in producing favourable results.  
Although many of the studies have explored some effects of PHVs on the costs to healthcare and 
social services, there are only a few studies on the cost-effectiveness of these interventions. The 
number of older people is growing fast. Cost-effective preventive interventions and support in 
connection with multimorbid s QOL are needed. PHV interventions suggest some 
favourable effects on s functioning and well-being, but more research into their 





The aim of this study was to examine the effects of preventive home visits to older people on their 
health-related quality of life (HRQoL) and the use and costs of healthcare and social services. 
 
Research questions in the individual studies were as follows: 
1. What is the evidence from earlier randomized controlled studies on the effects of PHVs on 
functioning, HRQoL, mortality and use and/or costs of healthcare and social services and 
cost-effectiveness of the effects of PHVs when reviewed systematically? (Study I and the 
update to the literature review).   
2. What are the baseline findings and practicability of the PHV study on independent home-
dwelling older adults (  75 years of age)? (Study II). 
3. What are the effects of a multiprofessional three-visit home-visit intervention programme on 
independent home-dwelling older adults (75+ years old) as regards their HRQoL and 
mortality in a two-year follow-up study? (Study III). 
4. What are the effects of a multiprofessional three-visit home-visit intervention programme on 
independent home-dwelling older adults (75+ years old) as regards the use and costs of 







Study I is a systematic review of randomized controlled trials (RCTs) examining the effectiveness 
social services, the costs involved and 
the -of-life (QOL) and 
mortality. Furthermore, in the literature review of this dissertation RCTs exploring the effectiveness 
of PHVs on independent home-dwelling older people were included. This review updates the 
Article I review and expands its focus beyond use and costs of services. For the review, PHVs were 
defined as visits to community-dwelling older people, concerning multidimensional medical, 
functional, psychosocial, and/or environmental evaluation of their problems and resources. 
Relevant RCTs were systematically sought in electronic databases (PubMed, Ovid Medline, 
Cochrane Database, DARE, and Cinahl) using keywords related to home visits for older people and 
economic analysis. The following terms were used: ((preventive OR prevention) AND (home care 
OR home nursing OR house calls OR home visit)) AND aged [MeSH Terms] AND (cost-
effectiveness OR economic OR cost-benefit analysis OR costs and cost analysis OR health care 
costs OR hospital admissions OR nursing home admissions) in all fields. Search terms (aged OR 
elderly OR older people OR old) were used in databases where aged  [MeSH Term] search was 
not possible. The original search was performed in May 2015, and it was repeated in February 2016 
and August 2018. The earlier reviews and reference lists from earlier papers were hand-searched for 
additional studies. The original search revealed 19 RCTs. The search in August 2018 was 
performed using the same search method as in 2015 and 2016, without the search terms and 
inclusion criteria concerning use and costs of healthcare and social services. This supplementary 






Figure 1. Flowchart of the systematic review. 
 
Papers identified in database searches in 2015 2016 
(n = 3219) 
Duplicates removed 
(n = 204) 
Reviews 
(n = 47) 
Randomized controlled  
trials (RCTs) 
(n = 293) 
New papers identified in 
database searches in 
2018 
(n = 14) 
Reviews 
(n = 22) 
searched for additional papers  
Articles assessed for 
eligibility 
(n = 114) 
Papers excluded: 
Not RCT (n = 1) 
Not home-visiting programme 
or no comparison group (n = 
44) 
Additional report of same data 
set (n = 36) 
No outcome data on use and 
costs of services (n = 8) 
Focused on specific diagnoses 
or study subjects were in 
hospital or institutions (n = 6) 
 
Papers included in 
evaluation 




The methodological quality of the included studies was evaluated by two independent researchers 
according to a ten-criteria rating system. If differences of opinion emerged, they were taken to a 
third researcher and discussed between the reviewers until a consensus was reached. The rating 
system applied the criteria for randomized intervention trials used by Cochrane and collaborators 
(The Cochrane Collaboration 2011), the Evidence-Based Medicine Working Group (Guyatt et al. 
1993, 1994) and the Joanna Briggs Institute MAStARI critical appraisal tool (The Joanna Briggs 
Institute 2011). 
The 10 criteria are described in detail below: 
(1) Inclusion and exclusion criteria are satisfactorily described. 
(2) Groups are comparable at baseline. 
(3) The study has sufficient statistical power to detect an effect and there was a strength calculation. 
(4) The randomization method is adequately described and the assignment to treatment groups was 
truly random. 
(5) The measurements and outcome measures are valid and well defined. 
(6) The intervention is adequately described. 
(7) The dropouts are described and the analyses take them into account. 
(8) Intention-to-treat analysis is applied. 
(9) A comparison is made in relation to outcome variables between the groups. 
(10) The group assignment is blinded when assessing the outcomes. 
- -
information was provided or information was unclear. Trials scoring 8 10 points were considered to 
be of high quality, whereas scores of 5 7 indicated moderate quality and < 5 indicated poor quality. 
 
In Studies II IV we report the results and practicability of a randomized controlled trial exploring 
the effects of multiprofessional preventive home-visit intervention on independent home-dwelling 
older adults in the Hyvinkää area.  
Older adults (  75 years of age) living at home in Hyvinkää municipality (n = 2,692) were 
contacted by a post in May 2013. The sample was obtained from the population registry office. The 
information letter sent explained the trial and invited these older adults to participate in it. Of these, 




study nurse contacted them. The inclusion criteria for the study were: 75 years old or more, 
independently home-dwelling without home help/nursing services, Finnish-speaking, able to 
provide informed concent, and living permanently in Hyvinkää. Based on the survey, 968 of those 
who returned the letter fulfilled the inclusion criteria. Of these, the first consecutive 422 persons 
giving their informed consent were recruited to the study.  
The follow-up time for the study was two years, and the same study letter was sent to participants at 
baseline and at one- and two-year time-points.  
The flow of participants and attrition rates are shown in Figure 2. The 15D data was missing for 
three participants in the intervention group and five participants in the control group only on one-
year timepoint, and for 24 participants in the intervention group and 33 in the control group only on 
two-years timepoint. All participants with at least one data point on 15D on follow-up were 
included in the analyses, therefore 89% (n = 189) of the intervention group and 87% (n = 185) of 
the control group were included in analyses. The use and costs of services data were collected for 
all participants until death or two-years time point. 
 
The study protocol for the RCT was approved by the Ethics Committee of Helsinki University 
Hospital (no. 215/13/03/00/12, year 2012). All participants provided written, informed consent 
before participation, after receiving oral and written information on the study protocol. Those 
participating in the study were able to provide informed concent and had no severe cognitive 
impairment which would have prevented this. 
 
For the primary outcome measure we used the 15-dimensional instrument (15D) to assess HRQoL 
(Sintonen 2001). The 15D is a comprehensive, generic, 15-dimensional assessment scale. It can be 
used both as a profile measure and as a single index score. The single index score on a scale from 0 
(poorest HRQoL) to 1 (excellent HRQoL) is calculated from the descriptive system of health state. 
The dimensions of the 15D questionnaire are mobility, vision, hearing, breathing, sleeping, eating, 
speech, elimination, usual activities, mental function, discomfort and symptoms, depression, 






























Hyvinkää city municipality, Finland, in May 2013 
Information letters sent to residents 75 years old or older (n=2,692) 
Health and well-being surveys were posted to those showing interest by 
sending a return letter (n=1,143). 
Did not return survey (n=175) 
Returned health and well-being surveys 
(n=968) 
Excluded (n=546): 
Fulfilling inclusion criteria but returning 
survey late (n=503) 
Did not meet inclusion criteria(n=43): 
Deceased before study started (n=8) 
Refused (n=17) 
Receiving regular home care or living in 
assisted living facility (n=16)  
Moved away (n=2) 
The first 422 consecutive eligible participants fulfilling inclusion criteria 
recruited. 
Randomised (n=422) 
Intervention group (n=211) Usual care group (n=211) 
Assessed at 1 year (n=186)  
3 deceased before 12 months, 9 too ill to 
continue, 10 not reached, 3 missing data 
from 1-year timepoint 
Assessed at 1 year (n=180) 
2 deceased before 12 months, 7 too ill to 
continue, 5 declined to continue, 12 not 
reached, 5 missing data from 1-year 
timepoint 
Assessed at 2 years (n=162) 
2 deceased before 24 months, 11 too ill 
to continue, 11 not reached. 
Assessed for use and costs of 
services (n = 211) 
Assessed at 2 years (n=147) 
6 deceased before 24 months, 11 too ill 
to continue, 16 not reached 
Assessed for use and costs of 




The 15D is a brief questionnaire which is designed to be self-administered (Sintonen 2001). It 
correlates well with other HRQoL measures and has good discriminative validity and prognostic 
validity in aged populations (Strandberg et al. 2006). It has shown better discriminatory power than 
the Nottingham Health Profile (Sintonen 2001, Hunt et al. 1986), and it is sensitive to changes after 
healthcare intervention (Kattainen et al. 2005). The minimum important change in HRQoL 
measured by the 15D instrument is 0.015 for improvement and -0.015 for deterioration (Alanne et 
al. 2015).  
Secondary outcome measures included use and costs of healthcare and social services, and 
mortality, which were retrieved from medical records and central registers up to two years after the 
first home visit. 
A feedback survey was performed in the intervention group after the home visits to assess the 
practicability of the intervention. The items in the survey were designed to explore the satisfaction 
of participants and to be consistent with the general aims of the intervention. The questions were: 
(1) Did you find the home visits beneficial? (2) Did you get new information about available 
services? (3) Did you receive new information on supporting or improving your health? (4) Has 
your health or functioning improved due to the home visits? (5) Has your well-being increased? (6) 
Do you wish to receive similar home visits in the future if there is an opportunity? The options for 
 The questionnaire was sent together with the one-
year follow-up survey and answered anonymously. 
 
At baseline we collected demographic data (age, gender, education, marital status), current height 
and weight, current medications, use of assistive devices, risk factors (smoking, use of alcohol, falls 
during the past six months), exercise habits, medical history and diagnoses (list of diseases with 
yes/no options) and HRQoL via the 15D measure. The data was collected by way of similar postal 
surveys at baseline and at follow-up at one-year and two-year time points. The use of prescription 
drugs was confirmed from medical records. We calculated the Charlson comorbidity index score 
(Charlson et al. 1987) based on diagnoses to evaluate the overall disease burden.  
Data on the use and costs of healthcare and social services were collected in detail for one year 
before the study and then for two years. All visits to primary-care physicians and nurses and other 
healthcare specialists (such as physiotherapists, occupational therapists, nutritionists and foot 




institutions (various hospitals, nursing homes or long-term care hospitals) were retrieved from 
-care facilities and all their area hospitals, and 
from social care registers.  
Costs of services were retrieved from the 2011 report by the Finnish National Institute for Health 
and Welfare as mean unit costs for Finland (Kapiainen et al. 2011) and correction was made for the 
inflation rate based on the official cost-of-living index. The number of health and social-care 
services utilization units were multiplied by the cost prices for each unit to calculate the total costs. 
The intervention costs were calculated according to the mean unit costs for the three home visits 
performed. Costs are presented in e   
Mortality dates were retrieved from central registers at the end of the study. 
 
The first 422 consecutive persons who fulfilled the inclusion criteria and gave their informed 
consent were randomized into intervention (n = 211) and control (n=211) groups. Randomization 
was performed using computer-generated random numbers from Research Randomizer (Urbaniak et 
al. 2013), seeded by the computer's clock. Two randomizations were performed as spouses (n = 
128) were randomized together to avoid dilution of the intervention effect. The control group 
received their typical care including the normal health and social care offered by the municipality, 
and the intervention group received the preventive home visits in addition to their typical care. 
 
The intervention consisted of multiprofessional home visits that utilized CGA. Professionals 
specially trained for the task delivered the three home visits. They also received written and oral 
instructions on performing the home visits. The professionals could consult and hold meetings with 
a physician of a geriatric ward, and with each other. The first home visit was delivered by a nurse, 
the second by a physiotherapist and the third by a social worker over a six- to nine-month period 
from the start of the intervention. The duration of the visits varied from half an hour to one and a 






The professionals used validated, structured tests for assessment at the home visits. They had 
unified instructions on the actions to be taken and recommendations to be given, based on the 
assessment results. In addition, the professionals gave individualized guidance and made 
individualized recommendations and referrals to other professionals and service providers 
according to the needs and wishes of the participant. The assessments used, guidance given, 
recommendations, and actions taken are described in Tables 6 and 7. 
 
Table 6. Instruments used in assessment. 
Instrument used in CGA 
during the PHV 
Domain assessed Cut-off point for 
intervention 
MMSE (Folstein et al. 2975) Cognition  24 points / 30 
GDS-15 (de Craen et al. 2003) Depression > 6 points / 15 
MNA screening (Guigoz et al. 
2002) 
Nutrition < 12 points / 14 
Barthel scale (Mahoney et al. 
1965) 
Functioning: Activities of 
daily living 
 Tailored / max 100 points 
Lawton IADL scale (Lawton 
et al. 1969) 
Functioning: Instrumental 
activities of daily living 
Tailored to needs and wishes 
of participant / max 8 points 
RAI-HC (Hirdes et al. 2008, 
Morris et al. 1999) 
Comprehensive assessment in 
a variety of domains 
As RAI Clinical Assessment 
Protocols suggest 
FROP-Com screen (Russell et 
al. 2008) 
Risk of falls 
Balance 
> 3 points / 9 
Jamar (Abizanda et al. 2012) Muscle strength by hand-grip 
strength 
< 32 kg for males and < 15 kg 
for females 
5 repetition chair-stand test 
(Guralnik et al. 1994) 
Physical functioning 
Risk of disability 
< 13.5 s 
Abbreviations: CGA = comprehensive geriatric assessment; PHV = preventive home visit; MMSE = Mini-Mental State 
Examination (Folstein et al. 1975); MNA = Mini Nutritional Assessment (Guigoz et al. 2002); RAI-HC = interRAI 
Home Care Assessment System (Hirdes et al. 2008, Morris et al. 1999); GDS-15 = Geriatric Depression Scale (de 
Craen et al. 2003); IADL = Instrumental Activities of Daily Living (Lawton et al. 1969); FROP-Com = Falls Risk for 
Older People  Community setting screen (Russell et al. 2008)
 
 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.8.1 Systematic review (I) 
In the systematic review (Study I) the RCTs were evaluated for their quality, outcomes and 
treatment effects. From each study the following data were extracted: location of the study setting, 
sample size, age of participants, gender distribution (if mentioned), inclusion and exclusion criteria, 
description of the intervention, duration and intensity of the intervention, deliverer of the home 
visits, outcome measures, and intervention effects. 
4.8.2 Intervention study (II IV) 
In the intervention study (Studies II IV) a power calculation was performed to estimate the sample 
size based on 15D measures. The calculation was based on a change of 0.03 points in the 15D score 
(Sintonen 2001). The standard deviation (SD) of 15D was 0.15 in prior studies (Pitkala et al. 2008). 
For a type 1 error of 5% and a power of 80% a minimum sample size of 196 study participants was 
needed per study arm, based on the calculation. 
The primary outcome (15D) was analysed according to a modified intention-to-treat principle. 
Participants who had a baseline assessment and at least one follow-up assessment were included in 
the analysis. In all analyses the level of statistical significance was 5% (p < 0.05). 
Regarding the baseline findings (Studies II IV), the groups are described in terms of proportions for 
categorial variables and means with standard deviations for continuous variables. For categorial 
variables, the 2 test and Fisher  exact test were used to test differences between the intervention 
and control groups.  t-test and the Mann Whitney U-test were used for continuous 
variables, as appropriate. Multiple imputations were performed for some missing 15D items, using 
the method of chained equations and five sets of imputations, as implemented in the Stata ice add-
on.  
Mean changes in the 15D score  (Studies III IV) were assessed using the mixed-model 
repeated measures method with treatment, visit, and treatment visit interaction as fixed effects. The 
model included age, sex, and the baseline score as covariates in Study III. We used Cox 
proportional hazards regression for the estimation of age, gender, and Charlson comorbidity index 
adjusted hazard ratios (mortality as outcome variable). In Study IV, the model included the baseline 
score as a covariate. Differences in the mean change in the 15D score between the intervention and 




In Study IV,  t-test, the bootstrap-type t-test, or the chi-square test were used to make 
statistical comparisons between the groups, as appropriate. Generalized linear models with a log-
link function and a Gaussian distribution were used to model means ratios (with 95% CIs) for costs. 
Bias-corrected bootstrapping (10,000 replications) was used to obtain the CIs for the means because 
of the skewed distribution of the use and costs of healthcare and social services. The bootstrap type 
t-test and generalized nonparametric Hodges-Lehmann median differences were used for 
comparisons between the groups for costs. In the analysis of use and costs of healthcare and social 
services all randomized participants were included (intention-to-treat) (Study IV). 
In Study IV, outcomes for the cost-utility analysis are expressed in terms of generic quality-adjusted 
life-years (QALYs), measured using HRQoL (15D instrument). The cost-utility analysis was 
performed in relation to QALY derived from the area under the curve calculation for the 15D score 
from baseline to last follow-up. For the 15D and QALY analysis all participants who completed the 
baseline assessment and at least one follow-up assessment were included. To avoid bias from 
missing data an imputation of missing follow-up observations of 15D (IG n = 22, CG n = 26) was 
created for analysing QALY using multiple imputation by chained equations (Royston 2004). All 
analysis variables were included in the imputation model. Multiple data sets (n=10) were generated 
to account for the uncertainty in imputed data. 
In Study IV, the incremental cost-effectiveness ratio (ICER) was evaluated as the ratio of the mean 
difference in cost to the mean difference in effect. To manage the uncertainty around point-
estimates of ICERs a bootstrap resampling with several (5000) datasets was created by resampling 
from the original data. Bootstrapped ICERs are presented on an incremental cost-effectiveness 
plane, where the vertical axis represents the difference in costs and the horizontal axis represents the 
difference in effectiveness in QALYs. On the vertical axis, costs nd 
d on the horizontal axis the effectiveness increases to the right 
the -
of treatment costing more and being less effective than regular care, whereas the -
quadrant represents the possibility of treatment being less costly and more effective. The number of 
estimates falling within each quadrant is denoted in percentages. These results of ICER bootstrap 
iterations plotted on the cost-effectiveness plane reflect the variability within the original study 
sample. Statistical analyses were performed using Stata statistical software version 15.0 (StataCorp, 






The systematic search conducted in 2015 and in 2016 yielded 3219 articles, of which 293 were 
RCTs. Reviews were searched for additional papers. Duplicate articles and studies not relevant on 
the basis of the abstract were removed, leaving 114 articles (Figure 1). 
These articles were examined in detail and 95 did not meet the inclusion criteria. Study protocols, 
studies that were not RCTs or did not have a comparison group, were not conducted on older people 
(aged 65+ years), did not include home visits, did not report outcome data on hospitalization, 
institutionalization or use or costs of healthcare and social services were excluded. Based on the 
definition of preventive home visits, studies that evaluated follow-up home visits directly related to 
recent hospital discharge, as well as studies in which the intervention was exclusively targeted to 
fall-prevention or cognitive function, were excluded. No language restrictions were imposed. We 
found 16 studies directly in the database searches, and three additional articles were found from 
earlier systematic reviews. The results of this initial search and evaluation of the 19 included trials 
are reported in Study I. Based on a supplementary systematic search conducted in August 2018, 14 
studies were added to the review. The supplementary search was not restricted to PHV studies with 
reports on use and costs of services. 
5.1.1 Methodological quality of the trials 
A modified rating system was used to assess the methodological quality of the 33 RCTs examining 
the effects of PHV interventions targeted to older people (Table 8). Of the trials, 19 were considered 
as being of high methodological quality, with scores of eight to ten out of ten (Behm et al. 2016, 
Bleijenberg et al. 2016, Bouman et al. 2008a, Brettschneider et al. 2015, Byles et al. 2004, 
Crawford Shearer et al. 2010, Fairhall et al. 2015, Granbom et al. 2017, Gustafsson et al. 2012, 
Imhof et al. 2012, Kono et al. 2012, 2013, Kono et al. 2016, Melis et al. 2008, Metzelthin et al. 
2015, Ploeg et al. 2010, Stuck et al. 1995, van Hout et al. 2010, van Rossum et al. 1993, Yamada et 
al. 2003) and 10 trials were considered as being of moderate methodological quality with scores of 
five to seven out of ten (Dalby et al. 2000, McEvan et al. 1990, Fabacher et al. 1994, Gunner-
Svensson et al. 1984, Hebert et al. 2001, Sahlen et al. 2006, 2008, Schraeder et al. 2001, Shapiro et 






            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            







Only four of the studies were considered to be of poor methodological quality, with a score of four 
or less out of ten (Frese et al. 2012, Hendriksen et al. 1984, Pathy et al. 1992, Sorensen et al.1988). 
Methodological problems most often recorded were lack of information on blinding the group 
assignment when assessing the outcomes, poorly described randomization methods, inadequate 
description of the trial drop-outs and lack of power calculation, or low statistical power. 
5.1.2 Characteristics of the trials 
The trials included in the literature review were performed in Europe (n = 20) (Behm et al. 2016, 
Bleijenberg et al. 2016, Bouman et al. 2008a, Brettschneider et al. 2015, McEvan et al. 1990, Frese 
et al. 2012, Granbom et al. 2017, Gunner-Svensson et al. 1984, Gustafsson et al. 2012, Hendriksen 
et al. 1984, Imhof et al. 2012, Melis et al. 2008, Metzelthin et al. 2015, Pathy et al. 1992, Sahlen et 
al. 2006, Sorensen et al.1988, Stuck et al. 2000, Van Hout et al. 2010, Van Rossum et al. 1993, 
Vetter et al. 1984), the U.S.A. (n = 5) (Crawford Shearer et al. 2010, Fabacher et al. 1994, 
Schraeder et al. 2001, Shapiro et al. 2002, Stuck et al.1995,), Japan (n = 3) (Kono et al. 2012, Kono 
et al. 2016, Yamada et al. 2003), Canada (n = 3) (Dalby et al.2000, Hebert et al. 2001, Ploeg et al. 
2010,) and Australia (n = 2) (Byles et al. 2004, Fairhall et al. 2015,). The included studies covered a 
total of 24,362 participants (range 59 to 4128).  
All of the studies were performed on independent home-dwelling older people (inclusion criteria for 
studies included in the literature review). Of the studies, 14 were performed on frail subjects, 
individuals with a decline in functioning or people at risk of functional decline (Bleijenberg et al. 
2016, Dalby et al.2000, Fairhall et al. 2015, Granbom et al. 2017, Gunner-Svensson et al. 1984, 
Hebert et al. 2001, Kono et al. 2012, Kono et al. 2016, Melis et al. 2008, Metzelthin et al. 2015, 
Ploeg et al. 2010, Schraeder et al. 2001, Shapiro et al. 2002, Van Hout et al. 2010, Yamada et al. 
2003). Most of the studies had been performed on subjects aged 70 years or more (Bouman et al. 
2008a, Byles et al. 2004, Dalby et al.2000, Fabacher et al. 1994, Fairhall et al. 2015, Frese et al. 
2012, Gunner-Svensson et al. 1984, Melis et al. 2008, Metzelthin et al. 2015, Vetter et al. 1984, 
Yamada et al. 2003) or 75 years or more (McEvan et al. 1990, Hebert et al. 2001, Hendriksen et al. 
1984, Ploeg et al. 2010, Sahlen et al. 2006, 2008, Shapiro et al. 2002, Sorensen et al.1988, Stuck et 
al.1995, Stuck et al. 2000, Van Hout et al. 2010, Van Rossum et al. 1993). Seven studies were 
focused on younger subjects (60+ or 65+) (Bleijenberg et al. 2016, Crawford Shearer et al. 2010, 
Granbom et al. 2017, Kono et al. 2012, Kono et al. 2016, Pathy et al. 1992, Schraeder et al. 2001) 




2012, Imhof et al. 2012). The mean age of the participants in the studies varied between 72 to 86 
years. Most of the trials included more female participants than males. 
In most of the studies, the control and intervention groups were balanced at baseline. Differences 
between intervention and control groups at baseline were reported in five studies (Fabacher et al. 
1994, Frese et al. 2012, Metzelthin et al. 2015, Sahlen et al. 2006, Schraeder et al. 2001). Of the 
included studies, two failed to report any baseline data on the participants (Gunner-Svensson et al. 
1984, Sorensen et al.1988) and five failed to report any baseline data on the functioning or health 
status of the participants (Crawford Shearer et al. 2010, Granbom et al. 2017, Hendriksen et al. 
1984, Pathy et al. 1992, Sahlen et al. 2006). Well-being or QOL of the participants at baseline were 
reported in 13 studies (Bleijenberg et al. 2016, Brettschneider et al. 2015, McEvan et al. 1990, 
Fairhall et al. 2015, Hebert et al. 2001, Imhof et al. 2012, Kono et al. 2012, Melis et al. 2008, Ploeg 
et al. 2010, Schraeder et al. 2001, Shapiro et al. 2002, van Hout et al. 2010, Yamada et al. 2003), 
and eight of the studies reported some baseline information on the cognitive status of the 
participants (McEvan et al. 1990, Fairhall et al. 2015, Imhof et al. 2012, Melis et al. 2008, Ploeg et 
al. 2010, Schraeder et al. 2001, Stuck et al. 2000, van Hout et al. 2010). Some information on the 
use and/or costs of healthcare and social services were reported at baseline in 12 studies (Bouman et 
al. 2008a, Brettschneider et al. 2015, Dalby et al. 2000, McEvan et al. 1990, Imhof et al. 2012, 
Metzelthin et al. 2015, Schraeder et al. 2001, Stuck et al. 1995, Stuck et al. 2000, van Hout et al. 
2010, van Rossum et al. 1993, Yamada et al. 2003). 
All of the studies included in the literature review reported the profession of the deliverer(s) of the 
intervention. Both multiprofessional PHV interventions (Behm et al. 2016, Brettschneider et al. 
2015, Byles et al. 2004, Fairhall et al. 2015, Gustafsson et al. 2012, Metzelthin et al. 2015, Sorensen 
et al. 1988) and PHV interventions delivered by a single professional were explored in these 
studies. In two studies the intervention was delivered by a team of two professionals (Shapiro et al. 
2002, Sorensen et al. 1988), three studies reported a multiprofessional team delivering the 
intervention (Behm et al. 2016, Brettschneider et al. 2015, Fairhall et al. 2015) and three studies 
reported a multiprofessional support team and meetings for the single professionals delivering the 
intervention (Byles et al. 2004, Gustafsson et al. 2012, Metzelthin et al. 2015). The professional 
most commonly delivering the intervention was a nurse, with 19 studies reporting this, usually a 
nurse with special training (Table 5). A single professional (varied professions: nurse, occupational 
therapist, physiotherapist, social worker, care manager or psychologist) was reported as the 
deliverer of the intervention in eight studies (Behm et al. 2016, Byles et al. 2004, Fabacher et al. 




2006). Trained medical students were reported as the deliverers of the intervention in one study 
(Frese et al. 2012) and one study reported health visitors having delivered the intervention (Pathy et 
al. 1992). However, both of these studies were of low methodological quality. 
The intensity of intervention varied in the PHV studies. The length of intervention and follow-up 
was from three months (Brettschneider et al. 2015, Crawford Shearer et al. 2010, Melis et al. 2008) 
to 48 months (Gunner-Svensson et al. 1984). The number of visits varied in the studies from one to 
two (Behm et al. 2016, Bleijenberg et al. 2016, Byles et al. 2004, Dalby et al. 2000, McEvan et al. 
1990, Gunner-Svensson et al. 1984, Gustafsson et al. 2012, Kono et al. 2012, Metzelthin et al. 2015, 
Vetter et al. 1984) to 10 12 and more during a year (Fairhall et al. 2015, Granbom et al. 2017, 
Hebert et al. 2001). A tailored intervention programme was used in 16 of the included trials 
(Bleijenberg et al. 2016, Byles et al. 2004, Brettschneider et al. 2015, Dalby et al. 2000, Fabacher et 
al. 1994, Fairhall et al. 2015, Granbom et al. 2017, Gunner-Svensson et al. 1984, Hendriksen et al. 
1984, Imhof et al. 2012, Metzelthin et al. 2015, Ploeg et al. 2010, Sahlen et al. 2006, Schraeder et 
al. 2001, Shapiro et al. 2002, van Hout et al. 2010), and 14 of the trials reported support to the 
intervention-group participants during follow-up, most commonly in the form of follow-up phone 
calls (Bouman et al. 2008a, Byles et al. 2004, Brettschneider et al. 2015, Dalby et al. 2000, 
Fabacher et al. 1994, Gunner-Svensson et al. 1984, Hendriksen et al. 1984, Imhof et al. 2012, Ploeg 
et al. 2010, Sahlen et al. 2006, Schraeder et al. 2001, Shapiro et al. 2002, Stuck et al. 1995, van 
Hout et al. 2010).  
The outcome measures used in the studies were varied. In most studies, several outcome measures 
were reported. Of the studies included in the literature review, 26 reported the effects of PHVs on 
functioning or frailty (Tables 5, 9 and 10), 19 reported the effects of PHVs on well-being and QOL 
(Tables 5, 9 and 10), 27 studies reported outcomes on some variables related to healthcare and 
social services use or costs (Tables 5, 9 and 10), and 20 reported effects of the intervention on 
mortality (Tables 5, 9 and 10). The outcome measures used in the included trials are described in 
more detail in the literature-review section of this dissertation and in Table 5.  
The important characteristics of the good- and moderate-quality studies having a potential impact 

















































































































































































Behm et al. 2016  0/+     No 86 No 1 12 Yes/No  
Bleijenberg et al. 2016 0 + 0 0 Yes 74 Yes  12 No  
Bouman et al. 2008a 0 0 0   76 No 8 18 No  
Brettschneider et al. 2015 0 0 + 0  85 No 3 3 Yes  
Byles et al. 2004 +  0 0/- Yes  No 1-2 36 Yes  
Crawford Shearer et al. 2010 0/+    No  No 6 3 No  
Fairhall et al. 2015 0 + 0 0/+ Yes 83 Yes 10+ 12 Yes  
Granbom et al. 2017  0/+   No 81 Yes 12 12 No  
Gustafsson et al. 2012  0/+   Yes 86 No 1 12 Yes/No  
Imhof et al. 2012 0 0/+ 0 0/+ Yes 85 No 4 9 No  
Kono et al. 2012, 2013  0/+  0 Yes 80 Yes 2 24 No  
Kono et al. 2016  +  0/- Yes 79 Yes 4 24 No  
Melis et al. 2008 + +  0/+  82 Yes 6 3 No  
Metzelthin et al. 2015 0 0  0/- No 77 Yes 2 6 Yes/No  
Ploeg et al. 2010 0 0 0 0  81 Yes 3 12 No  
Stuck et al. 1995  +  0/+ Yes 81 No 4 36 No  
van Hout et al. 2010 0 0 0 0  81 Yes  18 No  
van Rossum et al. 1993 0 0 0 0/+ Yes c.78 No  36 No  
Yamada et al. 2003 0/+     79 Yes 6 18 No  
RCT, randomiz  
st, according to individual needs; +, significant effect in experimental group; 0/+, favourable effect in some 
outcome measures compared with controls; 0/-, unfavourable effect in some outcome measures compared with 



















































































































































































Dalby et al. 2000    0 0  79 Yes  14 No  
McEvan et al. 1990 + 0 0 0   No 1-2 20 No  
Fabacher et al. 1994  0/+ 0 0 Yes 72 No 4 12 No  
Gunner-Svensson et al. 1984    0 Yes 79 No  48 No  
Hebert et al. 2001 0 0  0 0  80 Yes  12 No  
Sahlen et al. 2006, 2008 0  + 0/+ No 80 No 2 24 No  
Schraeder et al. 2001   + + 0 No 76 Yes 4 24 No  
Shapiro et al. 2002 +  + + Yes 77 Yes  18 No  
Stuck et al. 2000  0/+ 0 0/+ Yes 82 No 4 36 No  
Vetter et al. 1984  0  0/+ 0   No 1 24 No  
RCT, randomized controlled trial; P  
significant effect in experimental group; 0/+, favourable effect in some 
outcome measures compared with controls; 0, no difference between intervention and control groups. 
 
5.1.3 Effects on functioning, HRQoL and well-being, mortality, and use and costs of healthcare 
and social services 
Of the RCTs, 25/33 reported some favourable effects of PHVs (Table 5), and 22 of these studies 
were of good or moderate quality (Tables 5, 9 and 10). Favourable effects on functioning 
represented the most common finding in 13 trials (Behm et al. 2016, Bleijenberg et al. 2016, 
Fabacher et al. 1994, Fairhall et al. 2015, Granbom et al. 2017, Gustafsson et al. 2012, Imhof et al. 
2012, Kono et al. 2012, 2016, Melis et al. 2008, Schraeder et al. 2001, Stuck et al. 1995, 2000). 
Positive effects of PHVs on well-being and/or HRQoL were reported in seven studies (Byles et al. 
2004, Crawford Shearer et al. 2010, Melis et al. 2008, McEvan et al. 1990, Pathy et al. 1992, 
Shapiro et al. 2002, Yamada et al. 2003). The risk of death was significantly lower in the 




1992, Sahlen et al. 2006, Schraeder et al. 2001, Shapiro et al. 2002, Vetter et al. 1984) and one 
study reported a better chance of staying in the community, meaning the probability of dying or 
admitted to a nursing home was lower among participants in the intervention group compared with 
the control group (Frese et al. 2012). 
Overall, only a few studies revealed favourable effects on well-being and HRQoL. The effects were 
mostly detected in some dimension of well-being or QOL, and not the overall HRQoL. There was 
no clear relationship between favourable effects and intensity and duration of the intervention, or 
the deliverers of the intervention. Those older people with better functioning might be more likely 
to benefit from PHV intervention in respect of their well-being or HRQoL, but the relationship is 
unclear due to the small amount of studies with positive findings (Markle-Reid et al. 2006, 
Rubenstein et al. 2001, Stuck et al. 2002).  
Most PHV interventions did not affect well-being or HRQoL. One reason might be the measures 
used. EQ-5D and SF-36/RAND-36 were most commonly used for measuring HRQoL, and in most 
of such studies no differences between groups in HRQoL were detected in follow-up. The measures 
used might not be sensitive enough to show a difference in change in populations of older people.  
Favourable effects of PHVs on the use of healthcare and social services, and costs, were reported in 
ten studies (Fairhall et al. 2015, Hendriksen et al. 1984, Imhof et al. 2012, Kono et al. 2013, Melis 
et al. 2008, Sahlen et al. 2008, Shapiro et al. 2002, Stuck et al. 1995, 2000, van Rossum et al. 1993), 
and one study reported that intervention-group participants were more likely to stay in the 
community (not dying or institutionalized) compared with the control group (Frese et al. 2012). Of 
these studies, two were of poor methodological quality (Hendriksen et al. 1984, Frese et al. 2012). 
The intervention group was less likely to be institutionalized in three studies (Melis et al. 2008, 
Shapiro et al. 2002, Stuck et al. 1995), and less likely to be hospitalized in four (Imhof et al. 2012, 
Melis et al. 2008, Kono et al. 2013, van Rossum et al. 1993) compared with the control group. 
None of the studies included in the literature review showed statistically significant differences in 
total healthcare and social services costs between the intervention and control groups. Cost-
effectiveness was explored in five studies, three of which found the intervention to be cost-
effective, with varied levels of willingness to pay (Fairhall et al. 2015, Melis et al. 2008, Stuck et al. 
1995) and two found the intervention not to be cost-effective (Brettschneider et al. 2015, Metzelthin 
et al. 2015). 
Of the studies reporting some favourable effects on functioning, HRQoL or well-being, or 




al. 2016, Melis et al. 2008, Sahlen et al. 2006, Sahlen et al. 2008, Schraeder et al. 2001, Stuck et al. 
1995, Stuck et al. 2000). None of these studies reported the total costs to be significantly higher for 
the intervention group; thus the favourable results in these studies were produced cost-neutrally. 
Only five studies explored the cost-effectiveness of PHV interventions. Three of these found the 
intervention to be cost-effective (Fairhall et al. 2015, Melis et al. 2008, Stuck et al. 1995) and two 
reported the intervention not to be cost-effective (Brettschneider et al. 2015, Metzelthin et al. 2015). 
It is difficult to compare these studies with each other due to the variety of target groups, 
interventions and methods of evaluating cost-effectiveness. 
Table 9 summarizes the findings in PHV studies rated as being of high quality and Table 10 
summarizes the findings of the studies rated as being of moderate methodological quality. 
 
The mean age of the 422 participants was 81 years and 65% of the participants were female. The 
tion. Slightly more than half of 
the participants were cohabiting. The participants were mostly satisfied with their lives and HRQoL 
on the 15D measure was similar at baseline in both groups. Functional performance in usual 
activities of the participants was good at baseline, with over 80% of participants being able to 
perform their usual activities without difficulty or with only minor difficulty.  
There was no statistically significant difference between the groups in the Charlson comorbidity 
index. However, a slightly lower proportion of participants in the intervention group (n = 28, 13%) 
had a diabetes diagnosis compared with the control group (n = 46, 22%; p = 0.02). A slightly lower 
proportion of the participants in the intervention group used a walking aid than in the control group. 
However, there was no difference in mobility in 15D between the groups at baseline. There were no 
other significant differences between the groups at baseline, and HRQoL measured by means of the 
15D instrument was similar between the groups at baseline. Table 11 describes the characteristics of 
the participants at baseline. 
Persons of a similar age in the background population of Hyvinkää were slightly older (mean age 
81.6 years), and the proportion of married older people in the background population was slightly 
lower (41% vs. 51%). The proportion of females (65%) was similar in the trial participants 




Table 11. Characteristics of the participants of the preventive home visit (PHV) trial and their use 




(n = 211) 
Control group 
(n = 211) 
 
p value6 
Age, mean (SD1) 80.8 (4.3) 81.3 (4.3) 0.20 
Females, n (%) 138 (65) 136 (65) 0.84 
Cohabiting 110 (52) 105 (51) 0.70 
Education, years (SD1) 10.0 (3.9) 9.8 (3.7) 0.63 
Satisfaction with life, n (%): 
 Satisfied 
 Unsatisfied 










HRQoL2: 15D3 score (SD1) 0.82 (0.11) 0.82 (0.11) 0.87 
15D usual activities 1 2 173 (82) 172 (82) 0.90 
Charlson comorbidity index5 (SD1) 1.3 (1.3) 1.4 (1.5) 0.61 
BMI4 (SD1) 26.5 (5.0) 26.5 (4.9) 0.62 
Smoking: 
 Current, n (%) 









Alcohol risk use, n (%) 17 (8) 15 (7) 0.71 
Fallen during last 6 months, n (%) 68 (32) 54 (26) 0.14 
 30 min at least once per week, n (%) 149 (71) 145 (71) 0.88 
Uses a walking aid, n (%) 21 (10) 35 (17) 0.05 
Prescription medications regularly taken (SD1) 4.4 (2.6) 4.5 (2.9) 0.77 
Primary care use (previous year), mean (SD)    
   Nurse visits 2.31 (3.70) 2.57 (4.11) 0.52 
   General practitioner visits 1.93 (1.82) 1.89 (1.89) 0.83 
    0.61 (1.87) 0.44 (1.09) 0.27 
   Primary-care ward days 1.00 (6.44) 1.18 (5.76) 0.77 
   Day-care days 0.47 (4.92) 1.42 (9.43) 0.21 
Specialized medical care, mean (SD)    
   Outpatient visits 1.13 (1.86) 1.12 (1.95) 0.98 
   Emergency department visits 0.69 (1.25) 0.63 (1.14) 0.63 
   Hospital ward care days  0.99 (3.18) 1.16 (5.03) 0.70 
1SD = standard deviation; 2HRQoL = health-related quality of life; 3Sintonen 2001; 4BMI = body mass index; 5Charlson 
et al. 1987; 6Differences between groups tested using 2 





Drop-outs who had no data on 15D in follow-up were older (mean age 83.1 years, SD 4.6) and with 
lower HRQoL (mean 15D score 0.76, SD 0.12) at baseline than those who completed the study. 
However, there were no differences between dropouts in intervention and control groups at baseline 
on 15D score, age and sex. 
Data on use of healthcare and social services was retrieved for one year before the intervention to 
compare such use at baseline between the intervention and control groups. There were no 
significant differences in use of any of the collected healthcare and social services between the 
groups (Table 11). 
 
The PHV intervention used in the trial was simple, and transferable to other primary-care settings. 
Although some of the home visits had to be postponed to a later date, for example due to an acute 
illness, the professionals reported that all the home visits were carried out as planned. The 
professionals reported the implementation of structured assessments and instructed and planned 
interventions, and these were implemented as instructed. During their visits, the physiotherapist and 
social worker checked whether the participant had understood the instructions left by the prior 
visitor and the extent to which the participants had followed the instructions. The participants had 
mostly followed the instructions well. 
The short questionnaire used for evaluation of participant satisfaction with PHV intervention at the 
1-year follow-up time-point is described in Methods (section 4.4). The participants who received 
the home visits gave mostly favourable feedback. The response rate was good, with 81% of the 
intervention group returning the questionnaire. Of those who answered, 70% stated they received 
new information on available services, and 59% wished to receive home visits in future if there 
would be an opportunity. Only 13% did not find the home visits beneficial and 9% would not have 
wished for further home visits. However, 59% stated that their health or functioning had not 
improved after the home visits and 58% stated that their well-being had not improved. Health, 
functioning and well-being of the participants were likely to deteriorate during this one-year period, 
considering their age; thus this questionnaire was not a good measure for these variables. Table 12 






Table 12. Answers to feedback survey on the home visits. Reproduced with permission from 
European Geriatric Medicine. 
Question Yes n (%) No n (%) Could not say n (%) 
Did you find the home visits beneficial? 66 (40) 21 (13) 79 (48) 
Did you get new information about available 
services? 
118 (70) 21 (12) 30 (18) 
Did you receive new information on 
supporting or improving your health? 
73 (44) 47 (28) 46 (28) 
Has your health or functioning improved 
due to the home visits? 
8 (5) 101 (59) 61 (36) 
Has your well-being increased? 17 (10) 96 (58) 54 (32) 
Do you wish to receive similar home visits 
in the future if there is an opportunity? 
98 (59) 15 (9) 52 (32) 
 
 
5.4.1 Effects of PHV intervention on HRQoL and mortality in home-dwelling older people (III, 
IV) 
In the intervention group compared with the control group, HRQoL (15D score) declined 
significantly more slowly over time (p for group 0.18, for time < 0.001 and for group#time 0.043 
adjusted for age and sex). The difference in changes between groups in the 15D score was -0.015 
(95% CI -0.029 to -0.0016; p = 0.028 adjusted for age, sex, and baseline value) measured at the 
one-year follow-up. However, the effect became diluted once the visits ended, the difference 
between groups (-0.0093) being no longer significant (95% CI -0.031 to 0.013; p = 0.41 adjusted 
for age, sex, and baseline value; Figure 3) at the two-year follow-up. 
The dimensions of the 15D score showed favourable differences stemming from sleeping, mental 
functioning, discomfort/symptoms, and vitality at the one-year follow-up. However, the differences 
in these individual areas of 15D did not reach significance when adjusted for age, sex and baseline 
















Figure 3. Effects (mean with 95% confidence interval shown as point estimate and whiskers) of the 
intervention on the change in health-related quality of life on a 15D scale (adjusted for age, sex and 
baseline) at one-year and two-year follow-up points. Reproduced with permission from the 
Scandinavian Journal of Primary Health Care. 
 
Of the participants, 13 died during the two-year follow-up: five in the intervention group and eight 
in the control group. There was no significant difference in mortality between the groups. The 
hazard ratio in the control group was 2.4 (95% CI 0.7 to 9.1, p = 0.19 adjusted for age, sex, and the 











































Figure 4. Effects of the intervention on the dimensions of a 15D scale at the one-year follow-up. 
Reproduced with permission from the Scandinavian Journal of Primary Health Care.  
 
Although HRQoL (15D measure) had declined significantly more slowly at the one-year follow-up, 
there was no significant difference in QALYs between the intervention and control groups during 
two-year follow-up. In the intervention group the mean for QALYs was 0.819 (SD 0.112) whereas 
the respective figure in the control group was 0.812 (SD 0.114). The difference in QALYs between 
the groups was -0.007 (95% CI -0.029 to 0.015; p = 0.52). After performing an imputation the 
difference between the groups was -0.005 (95% CI -0.035 to 0.022; p=0.48). 
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5.4.2 Effects of PHV intervention on use and costs of services and cost-effectiveness of PHV 
intervention (IV) 
d costs of healthcare and social services per person-year during the 
two-year follow-up were analysed in the intervention and control groups (Table 13). In the 
intervention group the mean total cost per person-year in the 24-month follow-
8  
difference between the intervention and control groups in total costs (mean difference - -
The median total costs per person years in the 24-month follow-
 , 7231) in the control group 
(median difference - - The cost of the intervention was 
The findings did not change when the intervention costs were included in the total costs for the 
intervention group, the mean total cost per person at two-year follow-
When including the intervention costs the mean difference between groups was - -3766 to 
1633) (mean ratio 0.84 [0.55 to 1.13]). 
 
  





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































As there was a significant difference in the change of HRQoL between the groups, a bootstrap 
analysis was performed concerning QALYs in cost-utility analysis although there were no 
significant differences in QALYs gained. The bootstrap analysis helps to manage the uncertainty 
around point-estimates of ICERs and the plotting on cost-effectiveness plane reflects the variability 
within the original study sample. The cost-effectiveness plane in this cost-utility analysis shows 
Figure 5), which represents the 
probability of the intervention having more effect and lower costs compared with usual care. 
 
Figure 5. Incremental cost-effectiveness planes for costs and health-related quality of life outcomes 
of 5000 bootstrapped replicates. The percentages in the four quadrants denote the estimates that fell 
within each quadrant: 9.2% more costly, less effect on QALY, 14.0% more costly, more effect on 
QALY, 60.1% less costly, more effect on QALY and 16.7% less costly, less effect on QALY. 
Reproduced with permission from the The Journals of Gerontology, Series A, Medical Sciences, 
published in 2019 (10.1093/gerona/glz139). 
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In the PHV intervention trial (Studies II IV), no adverse events were recorded during the 
intervention. There were no drop-outs during the home-visit intervention, all visits were performed 
as planned, and compliance was mostly good. There were no significant differences in services use 
between the groups, and services use did not significantly increase in the intervention group 





The systematic review exploring the effectiveness of PHV interventions targeted to older people 
suggested that these interventions have some favourable effects on functioning, HRQoL and well-
being, and mortality. A few of the studies included in the review suggested favourable effects on the 
rates of institutionalization and hospitalization, but most of the studies did not reveal any effects on 
these. None of the studies showed significant differences between intervention and control groups 
in total costs of care. Those studies that reported favourable findings in functioning, HRQoL and 
well-being, or mortality, and reported costs of services use by the participants, suggested that the 
favourable findings were achieved cost-neutrally. 
Findings in the PHV intervention study, an RCT examining the effects of multiprofessional PHV 
intervention on the HRQoL of home-dwelling older people, suggested significant favourable effects 
on HRQoL measured on the 15D scale during the one-year follow-up. However, the effects were 
diluted at two-year follow-up, and were no longer significant between the intervention and control 
groups. No significant differences in QALYs gained, on use of healthcare and social services, nor 
total costs were shown between the groups. However, cost-utility analysis showed that the majority 
(60%) of ICERs fell in the domin that the intervention might 
be effective, with lower costs. As there was no significant difference between groups in the total 
costs, the effects of the intervention were seen to have been achieved cost-neutrally. 
 
The systematic literature review was conducted on RCTs, and the PHV intervention trial was 
conducted as an RCT. The most reliable evidence on the efficacy of an intervention is considered to 
be provided by RCT studies. The risks of bias are minimized by random allocation of patients. 
However, the quality of RCTs has to be evaluated before their reliability and relevance in care are 
considered (Guyatt et al. 1993). Unless the RCT has a methodologically appropriate study design, 
with good implementation, analysis and reporting, aiming to prevent systematic errors, it cannot 
produce reliable data. When considering RCT studies exploring complex multifactorial 
interventions, the possibility of biased external validity has to be kept in mind, as in an RCT setting 
the circumstances might be more controlled than in actual practice (Elkan et al. 2001). 
The review concerned published information, which might be a source of bias, as positive results 




a small or no clinical effect, which would suggest that null results in PVH intervention studies are 
also published. 
The heterogeneity of RCTs exploring the effects of PHV interventions is a challenge when 
comparing their results. Although the definition of PHV trials used in the present literature review 
was fairly narrow compared with some (Mayo-Wilson et al. 2014), the participants included in the 
trials, intervention components and intensity, and outcomes reported were varied. Thus, the possibly 
poor comparability of the studies needs to be remembered when interpreting the results. The 
challenge when comparing PHV studies in terms of their effectiveness has been discussed in earlier 
reviews (Beswick et al. 2008, Lin et al. 2012, van Haastregt et al. 2000). Due to the heterogeneity of 
the studies, a meta-analysis was not conducted as part of the present literature review. It has been 
stated that meta-analyses might not reliably show the effectiveness of PHV studies due to the 
heterogeneity of outcomes used and that of the populations of older people included in the studies, 
and variability in the health trajectories of older people (Lin et al. 2012).  
In the systematic review we used the PRISMA checklist (Moher et al. 2009) and thus rigorous 
methodology was employed. The systematic review fulfilled following methodological checklist 
items for reviews with no meta-analysis: study eligibility criteria described, information sources and 
search strategy described, study selection, data collection and data items defined, risk of bias of 
individual studies evaluated, and risk of bias across studies evaluated. The review did not state a 
separate review protocol and where it could be accessed, nor registration information. 
The present PHV intervention study was based on careful planning and a rigorous RCT setting. It 
included few exclusion criteria, thus including participants fairly representative of the background 
population of home-dwelling older people. The participants were independent home-dwelling 
people aged 75 years or more, receiving no regular home care and living in Hyvinkää municipality 
in Finland. Those in a respective age group in the background population were slightly older and 
more often single than the participants in the present PHV trial. People living in institutions and 
receiving regular home care are more likely to be older and single than those who fulfilled the 
inclusion criteria of the present PHV trial, which explains the differences between the participants 
and the background Hyvinkää population. 
The PHV intervention of three home visits by professionals was designed to be practicable and 
transferrable to other primary-care contexts.  CGA was implemented in the intervention, which has 
been proven to be effective in assessment and treatment of older people (Lundqvist et al. 2018, 




having received thorough training and instructions for implementation of the intervention. Validated 
measures were used for CGA assessment during the intervention. The intervention and further plans 
were individualized according to the needs and wishes of the participant.  
The randomization of the 422 participants into intervention and control groups appeared to be 
successful, and the groups were balanced at baseline. Spouses were randomized together to avoid 
contamination of the intervention effect. Compliance was good in the intervention group. Barriers 
to participating were low, as the professio
date could be changed if any barriers arose concerning the suggested date. All of the home visits 
were delivered according to plan, and there were no drop-outs in the intervention group during the 
intervention period. The PHV intervention was well received by the participants in the intervention 
group, with only 9% not wishing for further home visits. 
The control group did not receive any active intervention. They continued treatment as usual and 
were entitled to all the normal services for older people that the municipality offered. They could, 
for example, contact their GP or community nurse, have service needs assessment or see a 
physiotherapist if needed during the study period. The services offered to older people in Finland 
are in general of high quality, and this may have diluted the differences between the groups. The 
participants in the intervention group were not restricted in contacting the services the municipality 
offered or other healthcare and social-service providers if needed. In addition, the control group 
received and answered the same postal questionnaires as the intervention group. This may have also 
diluted the differences between the groups. Data on use of healthcare and social services were 
retrieved for both the intervention and control groups for the duration of the two-year follow up as 
part of the trial. However, there were no significant differences in the use of services between the 
intervention and control groups, which supports the hypothesis that favourable results achieved 
were due to the intervention. 
The primary outcome in the PHV trial was HRQoL (15D measure) (Sintonen 2001), which is a 
patient-relevant outcome measure. The 15D measure is self-reported and can be obtained by using a 
postal questionnaire. It has shown a good validity in older populations, and it is sensitive to changes 
after intervention (Alanne et al. 2015, Pitkala et al. 2009, Pitkala et al. 2014, Strandberg et al. 
2006). Of the total study population 11% (22 intervention participants and 26 control participants) 
did not have 15D information during the follow-up. The drop-out rate was low for a study targeting 
older people (ref). Although drop-outs were older and had lower baseline HRQoL than those who 




15D score, age and sex of the dropouts. Therefore, it is unlikely that the drop-outs would have 
influenced the outcome of the study. 
Secondary outcomes of the PHV trial were mortality and use and costs of healthcare and social 
services. There was no significant difference between the groups in mortality. The participants were 
fairly healthy older people, and the mortality rate of the participants during the trial was low. Most 
likely the study lacked the power to detect differences in mortality. 
The data on use and costs of healthcare and social services were collected one year before the 
intervention (baseline measures) and during two years of follow-up. The groups were balanced in 
their use of services at baseline. The costs of intervention were calculated on the basis of mean unit 
costs for healthcare and social services in Finland in 2011 (Kapiainen et al. 2011) with appropriate 
correction for the inflation rate added to the costs. The recording of use of services in Finnish 
medical records and central registers is reliable, so it is unlikely that any significant services-use 
data were missed. 
QALYs were used for the cost-utility analysis. As there was missing data on 15D due to drop-outs 
during follow-up, this missing data could have created bias in the results of the cost-utility analysis 
on QALYs and cost-effectiveness plane ICER plotting. An analysis with using multiple imputation 
by chained equations (10 datasets) was run and the results were similar to the original QALY 
analyses. Therefore, the chance of bias on cost-effectiveness analysis due to drop-outs is small. 
 
In the systematic review, the methodological quality of the included RCTs was mostly good, with 
19 out of 33 studies being of good quality. Only four of the studies included were of poor 
methodological quality. In earlier reviews PHV trials have been criticised for insufficient reporting 
of trial drop-outs, outcomes, and components of the interventions (Lin et al. 2012, Mayo-Wilson et 
al. 2014, van Haastregt et al. 2000). Many trials have also been found lacking in reporting of the 
treatment received by the control group and whether or not it was comparable between the studies, 
and in reporting the compliance of the participants (Bouman et al. 2008a, Mayo-Wilson et al. 2014, 
van Haastregt et al. 2000). The most typical methodological weaknesses in the studies included in 
the present review were associated with lack of information on blinding the group assignment when 
assessing the outcomes, and inadequate description of randomization methods. Furthermore, several 
investigators described the trial drop-outs inadequately or did not conduct an ITT analysis, or the 




sufficiently described the intervention, and inclusion and exclusion criteria, the outcome measures 
were mostly valid, and the groups were mostly appropriately compared in relation to the outcome 
measures. 
The variety of settings in which the RCTs were performed proves a challenge both in comparing the 
results of the studies and in generalizability to other settings and groups of older people. In studies 
of preventive, multifactorial interventions such as PHVs, differences in settings and usual care 
offered to the general older population might affect the results (Beswick et al. 2008, Mayo-Wilson 
et al. 2014). In addition, healthcare and social services offered by societies have developed greatly 
in the past few decades, proving a challenge in comparing results of older and newer studies. 
Furthermore, RCTs may be subject to selection bias, as the participants of intervention studies are 
often motivated and more active than non-participants, which might affect the generalizability of 
the results to other groups of older people (Martinson et al. 2010). However, most of the RCTs 
included in the present literature review presented fairly few exclusion criteria, and the intervention 
protocols were mostly designed to be practicable, which would support good transferability of the 
interventions to other primary-care settings and populations of older people. 
As stated in earlier reviews, there were not many common characteristics among the studies 
showing beneficial findings. However, the intensity of the intervention and sufficient follow-up 
with support might be features that increase the probability of favourable results, which is in line 
with earlier literature (Stuck et al. 2002). The intensity of the intervention seems to be associated 
with favourable findings on use and costs of services (Fairhall et al. 2015, Imhof et al. 2012, Melis 
et al. 2008, Shapiro et al. 2002, Stuck et al. 2000, Stuck et al. 1995, van Rossum et al. 1993). In 
studies with a relatively long follow-up but no support for the intervention group after initial 
intervention, the favourable effects became diluted during the follow-up period (Behm et al. 2016, 
Crawford Shearer et al. 2010, Sahlen et al. 2006, Schraeder et al. 2001). In addition, relatively well 
functioning older people aged 80 years or more might be more likely to benefit than those with poor 
functional status or those who are younger. This might be a result of ceiling and floor effects. With 
a relatively young population of older people, the effects of intervention might not show, as most of 
them are relatively fit and not at risk of functional disabilities or poor health outcomes. On the other 
hand, among those who already have functional disabilities, PHV interventions might not be able to 





Of the RCTs exploring the effects of PHV interventions targeted to home-dwelling older people, 22 
out of 33 revealed some favourable effects: 15 on functioning, seven on well-being and/or HRQoL, 
and seven on mortality. The effects, although significant, were mainly modest, and in three studies 
the favourable effects were restricted to a predetermined subgroup of participants (Kono et al. 2012, 
Vetter et al. 1984, Yamada et al. 2003). These findings are in line with those in several earlier 
reviews (Beswick et al. 2008, Elkan et al. 2001, Huss et al. 2008, Markle-Reid et al. 2006, Stuck et 
al. 2002, Toljamo et al. 2005). When a fairly unselected population of older people with different 
health trajectories is being targeted with multifactorial intervention to support general functioning, 
well-being or health, some might benefit considerably, some only modestly and some might not 
gain any benefit from the intervention (Lin et al. 2012). This heterogeneity in the effects of 
intervention among participants might be one factor explaining the modest findings. 
An earlier large review on various PHV interventions showed less favourable findings (Mayo-
Wilson et al. 2014). However, the inclusion of a large amount of studies targeted to different 
populations, with various interventions and outcomes measured and reported might have diluted the 
results. It has been proposed that meta-analyses suggesting minor or no effects might not mean that 
multifactorial interventions in PHV studies are ineffective. Minor effects might reflect the fact that 
some older adults gain substantial benefits whereas many might not gain any, when the variety of 
outcomes used to measure effects in heterogeneous populations of older people are considered (Lin 
et al. 2012). 
Of the RCTs exploring the effects of PHV interventions, 14 were performed on subjects with a 
decline in functioning or at risk of such a decline. In RCTs exploring the effects of PHVs, there 
were no major differences in the effectiveness of PHV interventions targeted to populations with 
functional decline or risk of it, and those which were targeted to populations with unselected 
functional ability. Earlier reviews have suggested that persons with relatively good functional status 
might benefit the most from PHV interventions (Stuck et al. 2002, Toljamo et al. 2005). It has been 
discussed that preventive programmes for older people might lead to poor participation and loss of 
cost-effectiveness if they are not properly targeted (Ford et al. 2017). Defining the best target group 
for PHV interventions is problematic, as most reviews have not pinpointed participant 




interventions from those to whom the visits might not be beneficial (Beswick et al. 2008, Elkan et 
al. 2001, Huss et al. 2008, Lin et al. 2012).  
In the RCTs included, no components of the PHV interventions appeared to distinguish 
programmes with favourable effects on functioning, well-being and HRQoL, and mortality from 
ineffective programmes. This is in line with the results of earlier reviews which suggest that PHV 
interventions of various designs can produce favourable effects (Beswick et al. 2008, Fagerström et 
al. 2009). It has been discussed that it might not be possible to separate which parts of the 
intervention are the effective elements when studying complex multifactorial interventions targeting 
older people (Beswick et al. 2008, Lin et al. 2012, Walker et al. 2017). Current research suggests 
that individualized and tailored interventions implementing CGA might have most potential in 
assessment, prevention, and health promotion targeted to older people (Beswick et al. 2008, 
Fagerström et al. 2009, Stuck et al. 2002). 
In the present RCT concerning multiprofessional PHV intervention, HRQoL (15D measure) in the 
intervention group declined more slowly than in the control group. HRQoL tends to deteriorate over 
time in older people (Fairhall et al. 2015, Kono et al. 2012, Shapiro et al. 2002). Thus, the PHV 
intervention was aimed at slowing down this deterioration. The positive effect was small but 
considered clinically significant (Alanne et al. 2015). The effect became diluted when the 
intervention was discontinued, and it was no longer significant at the two-year follow-up, which is 
in line with the results of several earlier studies (Behm et al. 2016, Sahlen et al. 2006, Schraeder et 
al. 2001, Stuck et al. 2002). The intervention did not include any support for the intervention-group 
participants during the follow-up period after the three initial home visits, and other studies have 
also shown dilution of favourable clinical effects of an intervention when lacking such support 
(Behm et al. 2016, Stuck et al. 2002).  
Only one of the included RCTs revealed a favourable effect on HRQoL (Yamada et al. 2003). Some 
studies have shown positive effects of home-visit interventions on well-being or dimensions of 
HRQoL of older people (Byles et al. 2004, Counsell et al. 2007, Pathy et al. 1992, Shapiro et al. 
2002), findings that the present trial confirm. However, in contrast to findings in the present RCT, 
many of the earlier trials failed to show significant favourable effects on HRQoL (Bleijenberg et al. 
2016, Bouman et al. 2008a, Brettschneider et al. 2015, Fairhall et al. 2015, Hebert et al. 2001, 
Imhof et al. 2012, Metzelthin et al. 2015, Ploeg et al. 2010, van Hout et al. 2010). A large review 




the trials we looked at showed adverse effects of the intervention on functioning, HRQoL or well-
being of the participants. 
In the present RCT, showing favourable effects on HRQoL, there were no inclusion or exclusion 
criteria based on functioning, and the participants had fairly good functional status at baseline. 
Many of the RCTs which did not show effects on HRQoL were performed on participants with a 
decline in functioning (Bleijenberg et al. 2016, Fairhall et al. 2015, Hebert et al. 2001, Metzelthin et 
al. 2015, Ploeg et al. 2010, van Hout et al. 2010). The participants in these studies might not have 
gained as much from the preventive intervention as participants with better functional status. 
Preventive interventions work best at early and reversible stages of disabilities and illnesses and 
participants with poor functional status might require more intensive intervention for any effects to 
show (Markle-Reid et al. 2006, Rubenstein et al. 2001). These findings are in line with those in 
earlier reviews suggesting that fairly well functioning older people benefit most from PHVs (Stuck 
et al. 2002, Toljamo et al. 2005).  
The null findings of some studies on the effects of PHV interventions on HRQoL of older people 
might be partly a result of the used HRQoL measures not being able to show a difference in change 
between groups in the study populations. The 15D measure has shown good validity in older 
populations and sensitivity to change in earlier studies (Kattainen et al. 2005, Pitkala et al. 2014, 
Strandberg et al. 2006). When studying intervention effects on HRQoL in populations of older 
people, the use of instruments that have been proven valid in older populations is of importance 
(Cummins 1997, Guyatt 2007). In an earlier review it was noted that the instruments used for 
assessing outcomes in PHV studies might not be sensitive enough to detect modest improvements 
in health or functional ability (Elkan et al. 2001). 
The present RCT did not show significant differences in mortality between the groups. The power 
of the trial might not have been large enough to show differences in mortality in a sample of fairly 
healthy older people. This finding on the effect on mortality is largely in line with the results of 
earlier studies. Although some of the earlier studies have shown PHVs to reduce mortality 
(Hendriksen et al. 1984, Pathy et al. 1992, Sahlen et al. 2006, Schraeder et al. 2001, Shapiro et al. 
2002, Vetter et al. 1984), most studies have not shown differences in mortality between the 
intervention and control groups. The more recent studies may have been unable to show favourable 
effects on mortality as nowadays the healthcare and social services offered to older people are likely 




There was no significant difference in QALYs gained between the intervention and control groups 
in the present RCT. Various factors might explain this. Firstly, no difference in mortality between 
groups was detected. Secondly, although the effect of the intervention on HRQoL was favourable, it 
was relatively modest and the effect diluted at the second year of follow-up. 
The results of the present trial on QALYs are in line with those in earlier RCTs exploring the effects 
of PHVs on QALYs, most of which showed no differences between groups (Brettschneider et al. 
2015, Fairhall et al. 2015, Metzelthin et al. 2015, Ploeg et al. 2010). Only one trial showed higher 
QALYs gained in the intervention group compared with the control group (Sahlen et al. 2008). The 
gained QALYs stemmed mainly from gained life years, as the mortality rate in the intervention 
group vs. the controls was lower. No significant difference in HRQoL was reported (Sahlen et al. 
2008). 
The uses of QALYs are limited when evaluating interventions aimed at promoting older peopl
health (Edlin 2014, Huter et al. 2016). Instruments used to assess QOL in intervention studies might 
not be sensitive enough in older populations and the measures used to calculate QALYs are usually 
limited to HRQoL. These might not capture non-health-focused effects important to older 
individuals, such as social effects or supported independence (Frytak 2000, Thompson et al. 2012, 
Vaarama 2009). Even healthy older people have a lower remaining life expectancy, which lowers 
the possible gain in life years, and in QALYs gained, compared with that of younger people. As 
most older people have comorbidities, the health gains according to HRQoL measures are often 
small and there is a risk of a floor effect (Melis et al. 2008). Thus, interventions targeting older 
people might lead to less improvement in QOL and smaller or non-significant differences between 
groups in QALYs gained, compared with interventions targeting younger populations (Edlin 2014, 
Huter et al. 2016, Melis et al. 2008). 
 
Of the RCTs exploring PHVs, 10 of 33 reported some favourable effects of intervention on 
healthcare and social services use and costs (Fairhall et al. 2015, Hendriksen et al. 1984, Imhof et 
al. 2012, Kono et al. 2013, Melis et al. 2008, Sahlen et al. 2008, Shapiro et al. 2002, Stuck et al. 
1995, Stuck et al. 2000, van Rossum et al. 1993). The most often reported effects were lower rates 
of institutionalization and/or hospitalization. The favourable findings were mostly modest. These 




effects on the use of healthcare and social services, with the favourable effects mostly stemming 
from less institutionalization in the intervention group (Beswick et al. 2008,  Elkan et al. 2001, 
Markle-Reid et al. 2006, Mayo-Wilson et al. 2014, Toljamo et al. 2005). None of the studies 
showed differences between intervention and control groups in total costs of healthcare and social 
services. 
The conclusions of two earlier reviews on the cost-effectiveness of PHVs were in line with the 
results of Study I. In both of the earlier systematic reviews it was stated that there is a lack of 
research on the cost-effectiveness of PHV interventions (Corrieri et al. 2011, Tappenden et al. 
2012). These reviews were performed on a narrower selection of trials compared with the present 
systematic review (I), one focusing on PHV intervention studies performed in Great Britain 
(Tappenden et al. 2012) and one focusing on fall-prevention trials (Corrieri et al. 2011). Only a few 
PHV trials (n = 5) have explored the cost-effectiveness of PHV interventions. It remains difficult to 
identify which elements of PHV trials might lead to cost-effective results (Corrieri et al. 2011, 
Tappenden et al. 2012). 
In the trials included in the systematic review (I), some reported more use of primary care, home 
care and social services in the intervention group compared with the control group (Hendriksen et 
al. 1984, Stuck et al.1995, Stuck et al. 2000, Vetter et al. 1984). However, the same studies revealed 
lower rates of institutionalization and mortality in the intervention group (Hendriksen et al. 1984, 
Stuck et al.1995, Stuck et al. 2000, Vetter et al. 1984). Thus, the increase in use of less resource-
intensive healthcare and social services in the intervention group could be seen as a neutral or 
desired effect of the intervention rather than an adverse effect. Only one trial showed more nursing-
home admissions in the intervention group compared with the control group (Byles et al. 2004). In 
one trial higher healthcare costs in the intervention group compared with controls were reported 
(Metzelthin et al. 2015), but in this trial the participants in the intervention group had more 
disabilities and were more likely to be frail at baseline compared with the controls. 
The results in the systematic review exploring RCTs are similar to those in earlier reviews on the 
effectiveness of PHVs on use and costs of healthcare and social services. Some studies have 
suggested favourable findings, but the findings remain modest. When comparing the studies, older 
people (80 years old or more) with relatively good functional status seem to benefit the most when 
focusing on PHV intervention effects on healthcare use and costs. The strongest association seems 
to be with the intensity of the intervention, with PHV programmes of four home visits or more 




multiprofessional PHV interventions implementing structured CGA and with sufficient follow-up 
visits would be more likely to produce favourable results on the use of costly services such as 
institutionalization (Stuck et al. 2002). However, earlier reviews have shown only modest and non-
significant effects, if any, of PHV interventions on rates of institutionalization and hospitalization 
(Bouman et al. 2008a, Huss et al. 2008, Mayo-Wilson et al. 2014, Stuck et al. 2002). The cost-
effectiveness of PHV interventions remains unclear, with only a few studies having explored it, 
none showing significant differences in total costs (Tappenden et al. 2012).  
, those 
performed among the oldest olds (mean age over 80 years) seemed more probable to produce 
beneficial effects on the use of services compared with those performed among the younger old 
population (Fairhall et al. 2015, Imhof et al. 2012, Melis et al. 2008, Stuck et al. 1995, Stuck et al. 
2000). This is in contrast to some earlier reviews that have suggested that younger populations of 
older people would benefit more (Huss et al. 2008, Stuck et al. 2002). However, earlier reviews 
have mostly explored clinical outcomes, and been focused less on the use and costs of services. 
O use of demanding healthcare and social services increases towards the end of their 
lives (Luppa et al. 2010, Ní Chróinín et al. 2018). As younger populations of older people are less 
likely to be hospitalized or institutionalized, showing a difference in use of services might be harder 
or require larger power in studies with participants consisting of younger older people. 
Most of the studies that have shown favourable effects on use and costs of services have been 
conducted on participants with fairly good functional status. Only three out of ten studies showing 
positive effects on use of services were targeted to older people with functional decline at the start 
of the study (Fairhall et al. 2015, Melis et al. 2008, Shapiro et al. 2002). An earlier review revealed 
similar results suggesting that older people with relatively good functional status would benefit the 
most from PHV interventions (Stuck et al. 2002). 
The number of home visits varied in the studies from one to over ten. The RCTs with four or more 
home visits more often produced beneficial effects on the use of services by the participants 
(Fairhall et al. 2015, Hendriksen et al. 1984, Imhof et al. 2012, Melis et al. 2008, Shapiro et al. 
2002, Stuck et al. 2000, Stuck et al. 1995, van Rossum et al. 1993). This finding supports the results 
of earlier research suggesting that the intensity of the intervention might influence its effectiveness 
(Stuck et al. 2002). In the present trial, the intensity of PHV intervention, with three home visits, 
may have been too low and more intensive intervention or support during follow-up might have 




In the present RCT the use of healthcare and social services by the intervention and control groups 
was balanced at baseline. Although the intervention group showed lower total costs, with the 
intervention costs included, the difference in the total costs of services was not statistically 
significant. This may be because the distribution of use and costs of services is often distinctly 
positively skewed (Briggs et al. 1998b). Showing a statistically significant difference between 
groups in costs of services might have required a larger number of participants than was included in 
the present RCT, the power of which was calculated on the basis of the primary outcome, HRQoL 
(15D measured) (Briggs et al. 1998b).  
The findings in the PHV intervention trial concerning total costs were similar to those in earlier 
studies exploring the effects of PHV interventions on total costs of healthcare and social services. 
None of the RCTs showed significant differences in total costs between intervention and control 
groups (Brettschneider et al. 2015, Fairhall et al. 2015, Kono et al. 2016, Melis et al. 2008, 
Metzelthin et al. 2015, Ploeg et al. 2010, Sahlen et al. 2008, Schraeder et al. 2001, Stuck et al. 1995, 
Stuck et al. 2000, van Rossum et al. 1993). 
Although there were no statistically significant differences in QALYs gained and total costs of 
healthcare and social services, the cost-utility analysis showed 60% of the ICERs lying in the 
dominant  quadrant of the cost-effectiveness plane. These results suggest that the intervention 
would possibly be superior to typical care offered by the municipality, being both more effective 
and less expensive (Briggs et al. 1998a). Of the earlier RCTs that presented ICERs on a cost-
effectiveness plane to evaluate cost-effectiveness of the intervention, one revealed that the 
was 34.6%, and the level at which the intervention 
would be cost-effective was a willingness to pay 34,000 euros (Melis et al. 2008). In contrast to the 
findings of the present RCT, one trial revealed the intervention not to be cost-effective, with only a 
2% probability of the intervention being en calculating ICERs (Metzelthin et al. 
2015). Both of these earlier RCTs were targeted to participants with functional decline at the start of 
the trial, which might be one reason for the less favourable results compared with those in the 
present PHV trial. Furthermore, if the measures used in these trials to detect the effect of the 
intervention were not sensitive enough in the target group of older people, the cost-effectiveness of 





The systematic literature review was conducted according to the guidelines on systematic reviews 
(Cochrane Handbook 2006, 2011, Moher et al. 2015). The inclusion criteria were determined before 
the search for and selection of studies. The review was based on a comprehensive search of RCT 
articles from databases and supplemented with a manual search for potential articles from the 
reference lists of relevant reviews. The flowchart of the study was presented to demonstrate the 
screening and selection of the studies. However, the review was conducted on published results 
only, which may have resulted in publication bias, influencing the results towards positive effects. 
The methodological quality of the studies was evaluated for risks of bias. Most of the trials were of 
good or moderate methodological quality. Of the studies included, four were of poor 
methodological quality, and three of them reported some positive effects. Thus, these results may be 
biased as a result of poor study methodology. The results of these studies were included in the 
systematic review for transparency, with mention and discussion of their poor quality. 
The heterogeneity of the PHV trials is a limitation in the present systematic review. The variety of 
interventions, target groups and outcomes measured and reported hindered comparison of the 
studies. Pooling of the data or performing a meta-analysis was not seen to be justified because of 
the heterogeneity of the studies. This has been earlier discussed in several reviews, which have 
stated the problems of pooling data from a variety of interventions and outcomes and the average 
effects of meta-analyses potentially underestimating the effects of complex interventions (Lin et al. 
2012, Toljamo et al. 2005, Van Haastregt et al 2000). The heterogeneity of the studies creates a 
challenge in detecting the key elements of the trials leading to positive results. Although many of 
the trials were designed to be practicable, the generalizability of the study results has to be 
evaluated in the context of the healthcare settings in which they originally took place. 
Some factors in the RCTs might lead to underestimation of the effects of the interventions. Some 
trials had a relatively low power (Crawford Shearer et al. 2010, Dalby et al. 2000, Granbom et al. 
2017, Shapiro et al. 2002), so they might not show the potential effectiveness of the PHV 
interventions adequately. Many of the studies involved light intervention. Although some of these 
studies produced some favourable results (Behm et al. 2016, Byles et al. 2004 McEvan et al. 1990, 
Frese et al. 2012, Gunner-Svensson et al. 1984, Gustafsson et al. 2012, Kono et al. 2012, Sahlen et 
al. 2006, Vetter et al. 1984), others did not show any positive effect (Metzelthin et al. 2015, 




Our PHV intervention targeted to older people had several strengths. It was a randomized, 
controlled trial with few exclusion criteria. The study had good power, with 422 participants 
randomized into two study arms and the groups were balanced at baseline. The PHV intervention 
programme was carefully planned and designed to be practicable and transferrable to other primary-
care contexts. The primary outcome measure, HRQoL (15D instrument) is clinically meaningful 
and well validated for older people. The 15D measure has proven to be sensitive to changes after 
intervention. The dropout rate in the analyses of HRQoL and QALYs was relatively low, with 88% 
of the intervention group and 85% of the control group having at least two 15D measurements 
included in the analysis. The data on use and costs of healthcare and social services were collected 
in detail. Finnish registers for mortality are 100% complete, and the healthcare and social services 
 A true intention-
to-treat analysis was performed in connection with the use of healthcare and social services of the 
participants and the costs involved. No adverse effects of the intervention were recorded. 
The multiprofessional PHV intervention was one strength of the study. The intervention included 
CGA, which has been shown to be effective in multifactorial interventions targeted to older people 
in earlier research (Dhesi et al. 2018, Ekdahl et al. 2016, Stuck et al. 2002). The intervention was 
semi-structured, with oral and written instructions to the professionals delivering it. Validated 
measures were used in the comprehensive assessment performed as part of the intervention. The 
intervention was individualized according to the needs of the participant. There were no drop-outs 
during the intervention, and all intervention visits were delivered according to plan. The PHV 
intervention was well received by the participants. 
The PHV trial has some limitations. The participants and deliverers of the intervention could not be 
blinded due to the nature of the trial, which exposes the study to a risk of bias. At the time of 
analysis the data was not blinded, although the analyses were performed following the intention-to-
treat principle. The light intervention protocol was practicable, but it might be less effective than 
more intensive PHV interventions. The participants were motivated volunteers, which is a common 
characteristic of RCTs. However, this might diminish the generalizability of the results to the 
general population. The Hawthorne effect cannot be ruled out as one dimension of the positive 
results on HRQoL among the intervention participants through the attention they received from the 
interveners. Although the trial included a large number of participants, the power might not have 






A systematic review of RCTs exploring the effects of PHV interventions targeted to older people 
suggested that the intervention produces some favourable effects on functioning, well-being and 
HRQoL, and mortality in a cost-neutral manner. However, the results were varied and the target 
groups benefitting most, as well as the elements of interventions producing the beneficial effects 
remain mostly unclear. There is a scarcity of research on the cost-effectiveness of PHV 
interventions. 
Based on the results of the systematic review of the RCTs, older people (over 80 years of age) of 
relatively good functional status might benefit the most from PHV interventions, when considering 
the effects on use of healthcare and social services. It seems that including CGA in the assessment 
and intervention is crucial in producing favourable effects. Interventions with four or more home 
visits and sufficient follow-up and support during follow-up might be more effective than lighter or 
shorter interventions, especially in producing favourable effects on the use and costs of healthcare 
and social services. 
A large RCT was conducted among independent community-dwelling older people, exploring the 
effects of multiprofessional PHV intervention on their HRQoL (15D measure) and use and costs of 
healthcare and social services. HRQoL declined significantly more slowly in the intervention group 
compared with the control group during the first year of follow-up, but the effect became diluted 
and was no longer significant at the two-year follow-up. The participants of this RCT were older 
people with fairly good functional status. 
No significant differences in mortality, QALYs gained or total costs between the groups were 
observed. Although there were no significant differences in total costs, 60% of the ICERs lay in the 
cost-effectiveness plane, suggesting that the intervention might be more 
effective and less costly than normal care. Thus, the conclusion is that the favourable effects on 





Although PHV interventions have been studied widely and also in large, good-quality RCTs, 
findings on their effectiveness remain controversial. Favourable effects on functioning, well-being 
and HRQoL, and mortality have been suggested in a variety of studies. However, studies with 
HRQoL and cost-effectiveness as outcomes are scarce. In addition, multiprofessional PHV 
interventions have been promising but less well studied. Prior PHVs have been mostly focused on 
-oriented and positive 
approaches to older people. Therefore, all these elements in PHV trials still need to be studied. 
Future studies should be targeted to relatively well functioning older people who are probably more 
likely to benefit from PHV interventions. Furthermore, the manner of support during follow-up and 
the required intensity of such support should be further studied. Research should focus on PHV 
interventions with sufficient intensity and support during follow-up. In addition, future studies 
should be based on implementation of CGA, which has shown effectiveness in earlier studies 
targeting older people. CGA includes a resource-oriented approach and aims to empower older 
people and support their coping. 
Several PVH trials have shown favourable effects. However, pragmatic implementation studies are 
needed in order to explore real-life effectiveness in various populations and countries. Researchers 
should describe the target groups, interventions and outcomes in detail in order to enable evaluation 
and comparison of PHV interventions and their effects. Large, possibly multi-centre studies on 
PHVs might produce new information on the effectiveness of PHV interventions and their key 
elements. 
Since PHVs have already shown several positive effects among older people, they should be 
implemented in primary care more widely. When disseminating PHVs in Finland, older people 
(over 80 years of age) with fairly good functional status seem to benefit the most from PHV 
interventions in regard to use and costs of healthcare and social services. Furthermore, interventions 
of sufficient intensity (  four home visits) delivered by interprofessional teams are more likely to 
produce favourable effects. If a PHV intervention is designed to reduce rates of institutionalization 
or hospitalization, it should be targeted to fairly independent older people of more advanced age and 
the intervention should be of sufficient intensity. CGA with a resource-oriented approach should be 
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Appendix 1. List of questionnaires included in baseline and follow-up postal surveys. 
 
1. Ikihyvä: 
Fogelholm Mikael, Haapola Ilkka, Absetz Pilvikki, Heinonen Heikki, Karisto Antti, Kasila 
Kirsti, Mäkelä Tiina, Seppänen Marjaana, Talja Martti, Uutela Antti, Valve Raisa ja 
Väänänen Ilkka. Ikihyvä Päijät-Häme -tutkimus. Perusraportti 2005.  
https://www.researchgate.net/publication/242260507_IKIHYVA_PAIJAT-HAME_-
TUTKIMUS_Perusraportti_2005 ; 2005 [accessed 16.1.2019] 
2. 15D: 
Sintonen H. The 15D instrument of health-related quality of life: properties and applications. 
Ann Med 2001;33:328-336. 
3. List of medications in use and a short questionnaire on risks of potential harms of 
medications. 
4. Additional questions: 




Appendix 2. Additional questions in baseline and follow-up postal surveys. 
LISÄKYSYMYKSET 
 
66. Tupakoitteko nykyisin, eli poltatteko savukkeita, sikareita tai piippua? 
 
 1 En 
 2 Kyllä 
 3 Olen lopettanut  ____ vuotta sitten 
 
67. Asun  
 1 Omakotitalossa 
 2 Rivitalossa 
 3 Kerrostalossa 
 4 Muu, mikä ?_______ 
 
68. Kotona liikkuminen on helppoa ja esteetöntä 
 1 Kyllä 
 2 Hieman vaikeuksia 
 3 Paljon vaikeuksia 
 








70. Asumisympäristössä liikkuminen on helppoa  
 1 Kyllä 
 2 Hieman vaikeuksia  
 3 Paljon vaikeuksia 
 
71. Mistä liikkumisvaikeudet asuinympäristössä johtuvat? Kirjoita vastauksesi vapaamuotoisesti 







72.  Pituuteni on ____ cm 
 









Appendix 3. List of measures used during nurse home visit. 
 
Physiological measurements: blood pressure, blood glucose 
The Barthel index (ADL): 
Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J 1965;14:61-65. 
http://www.thl.fi/toimia/tietokanta/mittariversio/84/ 
Geriatric Depression Scale GDS-15: 
de Craen AJ, Heeren TJ, Gussekloo J. Accuracy of the 15-item geriatric depression scale (GDS-15) in a 
community sample of the oldest old. Int J Geriatr Psychiatry 2003;18:63-66. 
http://www.thl.fi/toimia/tietokanta/mittariversio/87/ 
Measure available (in Finnish) at: http://www.muistiasiantuntijat.fi/media-files/testit/GDS-15.pdf [accessed 
17.1.2019] 
Lawton scale (IADL): 
Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily 
living. Gerontologist 1969;9:179-186. 
http://www.thl.fi/toimia/tietokanta/mittariversio/31/ 
Measure available (in Finnish) at: 
http://www.thl.fi/toimia/tietokanta/media/files/mittariversio/2012/06/11/IADL_lomake_toimia.pdf [accessed 
17.1.2019] 
Mini Mental State Examination MMSE: 
Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state 
of patients for the clinician. J Psychiatr Res 1975;12:189-198. 
http://www.thl.fi/toimia/tietokanta/mittariversio/91/ 
Measure available (in Finnish) at: http://www.muistiasiantuntijat.fi/media-files/testit/MMSE_150210.pdf 
[accessed 17.1.2019]  
MNA: 
Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The mini nutritional 
assessment. Clin Geriatr Med 2002;18:737-757. 
Measure available (in Finnish) at: http://www.muistiasiantuntijat.fi/media-files/testit/mna_mini_finnish.pdf 
[accessed 17.1.2019] 
RAI-HC: 
Morris JN, Fries BE, Bernabei R, Steel K, Gilgen R, DuPasquier JN, Fritzer D, Henrard JC, Hirdes JP. RAI-




Appendix 4. List of measures used during physiotherapist home visit. 
 
Falls Risk of Older People, FROP-Com screen: 
Russell MA, Hill KD, Blackberry I, Day LM, Dharmage SC. The reliability and predictive accuracy of the 
falls risk for older people in the community assessment (FROP-com) tool. Age Ageing 2008;37:634-639. 
Measure available (in Finnish) at: 
https://thl.fi/documents/966696/1449811/Lyhyt_kaatumisvaaran_arviointi_FROP-Com.pdf/fd90661a-bbcf-
48e6-8c0b-968a02c5ad06 [accessed 17.1.2019] 
Hand Grip Strength Jamar: 
Abizanda P, Navarro JL, Garcia-Tomas MI, Lopez-Jimenez E, Martinez-Sanchez E, Paterna G. Validity and 
usefulness of hand-held dynamometry for measuring muscle strength in community-dwelling older persons. 
Arch Gerontol Geriatr 2012;54:21-27. 
http://www.thl.fi/toimia/tietokanta/mittariversio/141/ 
Instructions for measuring available (in Finnish) at: 
http://www.thl.fi/toimia/tietokanta/media/files/mittariversio/2013/04/11/TOIMIA_suoritusohje_kaden_purist
usvoima.pdf 
Reference values available (in Finnish) at: 
http://www.thl.fi/toimia/tietokanta/media/files/mittariversio/2019/01/14/Puristusvoima_viitearvot_2017_TOI
MIA_ID041.pdf  
A chair-stand test, 5 times: 
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower 
extremity function: Association with self-reported disability and prediction of mortality and nursing home 
admission. J Gerontol 1994;49:85-94. 
http://www.thl.fi/toimia/tietokanta/mittariversio/155/ 
Instructions for measuring available (in Finnish) at: 
http://www.thl.fi/toimia/tietokanta/media/files/mittariversio/2014/03/10/TOIMIA_tuoliltanousu5x_suorituso
hje.pdf 









Appendix 5. List of measures used during social worker home visit. 
 
The Barthel index (ADL): 
Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J 1965;14:61-65. 
http://www.thl.fi/toimia/tietokanta/mittariversio/84/ 
Lawton scale (IADL): 
Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily 
living. Gerontologist 1969;9:179-186. 
http://www.thl.fi/toimia/tietokanta/mittariversio/31/ 
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